{ "as_of": "2026-10-29", "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS)", "fx_url": "https://www.bankofengland.co.uk/boeapps/database/", "rows": [ { "id": "DEAL-LC-137", "date": "2026-10-27", "year": "2026", "kind": "funding_round", "company_text": "adsilico (BIZ-SU-HLT-051)", "company_id": "BIZ-SU-HLT-051", "counterparty": "PXN Ventures (lead); Northern Gritstone; Parkwalk", "amount": 10000000, "amount_text": "10000000", "currency": "GBP", "valuation_reported": null, "summary": "Series A for generative AI and physics simulation of virtual patients to test medical devices.", "sources_text": "https://businesscloud.co.uk/news/adsilico-raises-10m-to-build-virtual-patient-populations/ — \"adsilico, a University of Leeds spinout, has raised £10 million in Series A funding.\" (trade, BusinessCloud)", "source_urls": [ "https://businesscloud.co.uk/news/adsilico-raises-10m-to-build-virtual-patient-populations/" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2026-10-27", "date_sort": "2026-10-27", "before_ledger_start": false, "amount_gbp": 10000000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£10m", "gbp_txt": "£10m", "show": true }, { "id": "DEAL-SU-HLT-001", "date": "2026-09-23", "year": "2026", "kind": "funding_round", "company_text": "Cascader (BIZ-SU-HLT-035)", "company_id": "BIZ-SU-HLT-035", "counterparty": null, "amount": null, "amount_text": null, "currency": null, "valuation_reported": null, "summary": "Seed round completed; amount and investors not disclosed.", "sources_text": "https://htn.co.uk/2026/09/23/moorfields-ai-spinout-cascader-completes-seed-funding-round/ — \"An AI spinout from Moorfields Eye Hospital NHS Foundation Trust\" (accessed 2026-10-29)", "source_urls": [ "https://htn.co.uk/2026/09/23/moorfields-ai-spinout-cascader-completes-seed-funding-round/" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2026-09-23", "date_sort": "2026-09-23", "before_ledger_start": false, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-LC-124", "date": "2026-09-21", "year": "2026", "kind": "funding_round", "company_text": "Big Picture Bio (new)", "company_id": "BIZ-SU-HLT-805", "counterparty": "not named", "amount": 2550000, "amount_text": "2550000", "currency": "EUR", "valuation_reported": null, "summary": "Emerged from stealth with funding for AI-designed cancer drug combinations (tech.eu recap, week to 21 September 2026).", "sources_text": "https://tech.eu/2026/09/21/european-tech-weekly-recap-over-eur17b-invested-across-70-deals — \"to develop AI-designed cancer drug combinations\" (trade, tech.eu)", "source_urls": [ "https://tech.eu/2026/09/21/european-tech-weekly-recap-over-eur17b-invested-across-70-deals" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2026-09-21", "date_sort": "2026-09-21", "before_ledger_start": false, "amount_gbp": 2187527, "fx_rate": 1.1657, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), €1.1657 per £ on 2026-09-21", "fx_date": "2026-09-21", "fx_note": "", "txt": "€2.5m", "gbp_txt": "£2.2m", "show": true }, { "id": "DEAL-SU-HLT-002", "date": "2026-09-15", "year": "2026", "kind": "funding_round", "company_text": "Magnitude Biosciences (BIZ-SU-HLT-020)", "company_id": "BIZ-SU-HLT-020", "counterparty": "Northstar Ventures", "amount": 1300000, "amount_text": "1300000", "currency": "GBP", "valuation_reported": null, "summary": "Round with Maven-managed regional funds and angels.", "sources_text": "https://www.uktech.news/funding/magnitude-biosciences-raises-1-3m-to-scale-drug-discovery-platform-20260915 — \"Northstar Ventures led the £1.3m funding round,\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/funding/magnitude-biosciences-raises-1-3m-to-scale-drug-discovery-platform-20260915" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2026-09-15", "date_sort": "2026-09-15", "before_ledger_start": false, "amount_gbp": 1300000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.3m", "gbp_txt": "£1.3m", "show": true }, { "id": "DEAL-SU-HLT-003", "date": "2026-09-04", "year": "2026", "kind": "spin_out", "company_text": "Dexter AI (BIZ-SU-HLT-036)", "company_id": "BIZ-SU-HLT-036", "counterparty": "University of Birmingham", "amount": null, "amount_text": null, "currency": null, "valuation_reported": null, "summary": "Launched as a University of Birmingham spin-out.", "sources_text": "https://htn.co.uk/2026/09/04/university-of-birmingham-ai-spin-out-launches-to-facilitate-data-extraction-from-ehrs/ — \"An AI spin-out from the University of Birmingham has launched\" (accessed 2026-10-29)", "source_urls": [ "https://htn.co.uk/2026/09/04/university-of-birmingham-ai-spin-out-launches-to-facilitate-data-extraction-from-ehrs/" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2026-09-04", "date_sort": "2026-09-04", "before_ledger_start": false, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-INV-2010", "date": "2026-07-31", "year": "2026", "kind": "funding_round", "company_text": "Qureight", "company_id": "BIZ-SU-HLT-009", "counterparty": "Molten Ventures, Hargreave Hale AIM VCT, XTX Ventures, Guinness Ventures and others", "amount": null, "amount_text": "15m", "currency": "GBP", "valuation_reported": null, "summary": "Qureight (3D deep learning platform) raised £15m (Series B), reported by UKTN weekly roundup.", "sources_text": "https://www.uktech.news/funding/uk-tech-funding-roundup-this-weeks-deals-from-dwelly-to-20260731 — \"develops a digital infrastructure and 3D deep learning platform\" (trade)", "source_urls": [ "https://www.uktech.news/funding/uk-tech-funding-roundup-this-weeks-deals-from-dwelly-to-20260731" ], "confidence": "single_source", "ledger": "page", "page": "investors", "render": true, "date_text": "2026-07-31 (week ending)", "date_sort": "2026-07-31", "before_ledger_start": false, "week_ending": true, "trade": true, "round4": true, "amount_as_written": "15m", "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "15m GBP", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-004", "date": "2026-07-29", "year": "2026", "kind": "funding_round", "company_text": "Qureight (BIZ-SU-HLT-009)", "company_id": "BIZ-SU-HLT-009", "counterparty": "Molten Ventures", "amount": 20000000, "amount_text": "20000000", "currency": "USD", "valuation_reported": null, "summary": "Series B for its AI clinical trial imaging platform.", "sources_text": "https://www.uktech.news/medtech/qureight-closes-15m-round-to-scale-ai-imaging-platform-20260729 — \"The round was led by Molten Ventures\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/qureight-closes-15m-round-to-scale-ai-imaging-platform-20260729" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2026-07-29", "date_sort": "2026-07-29", "before_ledger_start": false, "amount_gbp": 15052307, "fx_rate": 1.3287, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.3287 per £ on 2026-07-29", "fx_date": "2026-07-29", "fx_note": "", "txt": "US$20m", "gbp_txt": "£15.1m", "show": true }, { "id": "DEAL-SU-HLT-005", "date": "2026-07-24", "year": "2026", "kind": "funding_round", "company_text": "TidalSense (BIZ-SU-HLT-008)", "company_id": "BIZ-SU-HLT-008", "counterparty": "Cross-Border Impact Ventures; BGF; Airstream Capital; Foresight Group", "amount": 14200000, "amount_text": "14200000", "currency": "GBP", "valuation_reported": null, "summary": "Round to sell its COPD breath test in Europe and the US (lead not stated).", "sources_text": "https://www.uktech.news/medtech/tidalsense-secures-14-2m-for-ai-breath-test-20260724 — $19m (£14.2m) (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/tidalsense-secures-14-2m-for-ai-breath-test-20260724" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2026-07-24", "date_sort": "2026-07-24", "before_ledger_start": false, "amount_gbp": 14200000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£14.2m", "gbp_txt": "£14.2m", "show": true }, { "id": "DEAL-INV-2015", "date": "2026-07-24", "year": "2026", "kind": "funding_round", "company_text": "TidalSense", "company_id": "BIZ-SU-HLT-008", "counterparty": "Cross-Border Impact Ventures, BGF, Airstream Capital, Foresight Group", "amount": null, "amount_text": "14.2m", "currency": "GBP", "valuation_reported": null, "summary": "TidalSense (AI respiratory diagnostic device) raised £14.2m (Not stated), reported by UKTN weekly roundup.", "sources_text": "https://www.uktech.news/news/uk-tech-funding-roundup-cuspai-ponda-20260724 — \"a handheld AI-powered respiratory diagnostic device\" (trade)", "source_urls": [ "https://www.uktech.news/news/uk-tech-funding-roundup-cuspai-ponda-20260724" ], "confidence": "single_source", "ledger": "page", "page": "investors", "render": true, "date_text": "2026-07-24 (week ending)", "date_sort": "2026-07-24", "before_ledger_start": false, "week_ending": true, "trade": true, "round4": true, "amount_as_written": "14.2m", "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "14.2m GBP", "gbp_txt": "", "show": true }, { "id": "DEAL-UG-001", "date": "2026-07-16", "year": "2026", "kind": "funding_round", "company_text": "BeCertain (new)", "company_id": "BIZ-SU-HLT-502", "counterparty": "SVV (Sure Valley Ventures)", "amount": 1700000, "amount_text": "1700000", "currency": "GBP", "valuation_reported": null, "summary": "£1.7m pre-seed round for the King's and Surrey dental-imaging AI spin-out.", "sources_text": "https://www.kcl.ac.uk/news/university-spin-out-becertain-raises-1.7-million-to-bring-clinical-grade-ai-to-dental-diagnostics — \"pre-seed investment round\"", "source_urls": [ "https://www.kcl.ac.uk/news/university-spin-out-becertain-raises-1.7-million-to-bring-clinical-grade-ai-to-dental-diagnostics" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2026-07-16", "date_sort": "2026-07-16", "before_ledger_start": false, "amount_gbp": 1700000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.7m", "gbp_txt": "£1.7m", "show": true }, { "id": "DEAL-LC-103", "date": "2026-07-06", "year": "2026", "kind": "acquisition", "company_text": "Ogma (new)", "company_id": "BIZ-SU-HLT-705", "counterparty": "Saltroad", "amount": null, "amount_text": null, "currency": null, "valuation_reported": null, "summary": "Speech therapy company Saltroad, which raised £1.5M, bought AI platform Ogma to scale speech therapy for children (tech.eu recap, week to 6 July 2026).", "sources_text": "https://tech.eu/2026/07/06/european-tech-weekly-recap-more-than-55-tech-funding-deals-worth-over-eur16b/ — \"AI platform Ogma to scale speech therapy for children\" (trade, tech.eu)", "source_urls": [ "https://tech.eu/2026/07/06/european-tech-weekly-recap-more-than-55-tech-funding-deals-worth-over-eur16b/" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2026-07-06", "date_sort": "2026-07-06", "before_ledger_start": false, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-006", "date": "2026-06-19", "year": "2026", "kind": "funding_round", "company_text": "Frontier Health (BIZ-SU-HLT-014)", "company_id": "BIZ-SU-HLT-014", "counterparty": "Atomico", "amount": 16000000, "amount_text": "16000000", "currency": "USD", "valuation_reported": null, "summary": "Seed round with firstminute capital and XYZ.", "sources_text": "https://www.uktech.news/medtech/ai-health-tech-from-ex-palantir-lead-raises-12m-20260619 — $16m (£12.09m) seed led by Atomico (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/ai-health-tech-from-ex-palantir-lead-raises-12m-20260619" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2026-06-19", "date_sort": "2026-06-19", "before_ledger_start": false, "amount_gbp": 12092812, "fx_rate": 1.3231, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.3231 per £ on 2026-06-19", "fx_date": "2026-06-19", "fx_note": "", "txt": "US$16m", "gbp_txt": "£12.1m", "show": true }, { "id": "DEAL-INV-2031", "date": "2026-06-19", "year": "2026", "kind": "funding_round", "company_text": "Frontier Health", "company_id": "BIZ-SU-HLT-014", "counterparty": "Atomico, firstminute capital, XYZ", "amount": null, "amount_text": "12m", "currency": "GBP", "valuation_reported": null, "summary": "Frontier Health (AI operations assistant for NHS trusts) raised £12m (Seed), reported by UKTN weekly roundup.", "sources_text": "https://www.uktech.news/funding/uk-tech-funding-roundup-conduct-flagright-20260619 — \"AI operational teammate deployed across NHS Trusts\" (trade)", "source_urls": [ "https://www.uktech.news/funding/uk-tech-funding-roundup-conduct-flagright-20260619" ], "confidence": "single_source", "ledger": "page", "page": "investors", "render": true, "date_text": "2026-06-19 (week ending)", "date_sort": "2026-06-19", "before_ledger_start": false, "week_ending": true, "trade": true, "round4": true, "amount_as_written": "12m", "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "12m GBP", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-007", "date": "2026-06-03", "year": "2026", "kind": "funding_round", "company_text": "Flok Health (BIZ-SU-HLT-015)", "company_id": "BIZ-SU-HLT-015", "counterparty": "Albion VC", "amount": 12500000, "amount_text": "12500000", "currency": "USD", "valuation_reported": null, "summary": "Series A with Eka VC, Form Ventures and Mercia Ventures.", "sources_text": "https://www.uktech.news/medtech/flok-health-raises-9-3m-to-scale-its-ai-clinician-20260603 — $12.5m (£9.5m) Series A led by Albion VC (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/flok-health-raises-9-3m-to-scale-its-ai-clinician-20260603" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2026-06-03", "date_sort": "2026-06-03", "before_ledger_start": false, "amount_gbp": 9302672, "fx_rate": 1.3437, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.3437 per £ on 2026-06-03", "fx_date": "2026-06-03", "fx_note": "", "txt": "US$12.5m", "gbp_txt": "£9.3m", "show": true }, { "id": "DEAL-INV-2038", "date": "2026-05-29", "year": "2026", "kind": "funding_round", "company_text": "Perceptic", "company_id": "BIZ-SU-HLT-806", "counterparty": "Accel, Air Street Capital, Elder Gull", "amount": null, "amount_text": "9m", "currency": "GBP", "valuation_reported": null, "summary": "Perceptic (AI drug discovery platform) raised £9m (Seed), reported by UKTN weekly roundup.", "sources_text": "https://www.uktech.news/funding/uk-tech-funding-roundup-this-weeks-deals-from-inherent-to-mykor-20260529 — \"develops a unified AI platform to optimise drug discovery.\" (trade)", "source_urls": [ "https://www.uktech.news/funding/uk-tech-funding-roundup-this-weeks-deals-from-inherent-to-mykor-20260529" ], "confidence": "single_source", "ledger": "page", "page": "investors", "render": true, "date_text": "2026-05-29 (week ending)", "date_sort": "2026-05-29", "before_ledger_start": false, "week_ending": true, "trade": true, "round4": true, "amount_as_written": "9m", "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "9m GBP", "gbp_txt": "", "show": true }, { "id": "DEAL-LC-094", "date": "2026-05-28", "year": "2026", "kind": "funding_round", "company_text": "Perceptic (new)", "company_id": "BIZ-SU-HLT-806", "counterparty": "Accel; Air Street Capital; Elder Gull (leads)", "amount": 12000000, "amount_text": "12000000", "currency": "USD", "valuation_reported": null, "summary": "Seed for one AI system linking research, development and clinical decisions in drug development.", "sources_text": "https://www.uktech.news/ai/perceptic-raises-9m-to-boost-ai-system-for-drug-discovery-and-development-20260528 — \"Perceptic has raised a $12m (£9m) seed round led by Accel, Air Street Capital and Elder Gull\" (trade, UKTN)", "source_urls": [ "https://www.uktech.news/ai/perceptic-raises-9m-to-boost-ai-system-for-drug-discovery-and-development-20260528" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2026-05-28", "date_sort": "2026-05-28", "before_ledger_start": false, "amount_gbp": 8933889, "fx_rate": 1.3432, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.3432 per £ on 2026-05-28", "fx_date": "2026-05-28", "fx_note": "", "txt": "US$12m", "gbp_txt": "£8.9m", "show": true }, { "id": "DEAL-INV-2057", "date": "2026-04-03", "year": "2026", "kind": "funding_round", "company_text": "Lucida Medical", "company_id": "BIZ-SU-HLT-011", "counterparty": "IW Capital, XTX Ventures, Macmillan Cancer Support", "amount": null, "amount_text": "8.7m", "currency": "GBP", "valuation_reported": null, "summary": "Lucida Medical (AI cancer diagnostics) raised £8.7m (Not stated), reported by UKTN weekly roundup.", "sources_text": "https://www.uktech.news/funding/uk-tech-funding-roundup-this-weeks-deals-from-9fin-to-riplo-20260402 — \"has developed an AI-powered diagnostic service\" (trade)", "source_urls": [ "https://www.uktech.news/funding/uk-tech-funding-roundup-this-weeks-deals-from-9fin-to-riplo-20260402" ], "confidence": "single_source", "ledger": "page", "page": "investors", "render": true, "date_text": "2026-04-03 (week ending)", "date_sort": "2026-04-03", "before_ledger_start": false, "week_ending": true, "trade": true, "round4": true, "amount_as_written": "8.7m", "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "8.7m GBP", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-008", "date": "2026-03-30", "year": "2026", "kind": "funding_round", "company_text": "Lucida Medical (BIZ-SU-HLT-011)", "company_id": "BIZ-SU-HLT-011", "counterparty": "IW Capital", "amount": 8700000, "amount_text": "8700000", "currency": "GBP", "valuation_reported": null, "summary": "Round with XTX Ventures and Macmillan Cancer Support.", "sources_text": "https://www.uktech.news/medtech/ai-diagnostic-startup-raises-9m-in-macmillan-backed-round-20260330 — \"has raised £8.7m in a funding round.\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/ai-diagnostic-startup-raises-9m-in-macmillan-backed-round-20260330" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2026-03-30", "date_sort": "2026-03-30", "before_ledger_start": false, "amount_gbp": 8700000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£8.7m", "gbp_txt": "£8.7m", "show": true }, { "id": "DEAL-SU-HLT-009", "date": "2026-03-20", "year": "2026", "kind": "funding_round", "company_text": "Flexzo AI (BIZ-SU-HLT-018)", "company_id": "BIZ-SU-HLT-018", "counterparty": "Octopus Ventures", "amount": 12000000, "amount_text": "12000000", "currency": "USD", "valuation_reported": null, "summary": "Series A with Fuel Ventures.", "sources_text": "https://www.uktech.news/ai/agentic-healthcare-platform-flexzo-ai-raises-9m-20260320 — \"completed a $12m (£8.9m) Series A funding round\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/ai/agentic-healthcare-platform-flexzo-ai-raises-9m-20260320" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2026-03-20", "date_sort": "2026-03-20", "before_ledger_start": false, "amount_gbp": 9021200, "fx_rate": 1.3302, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.3302 per £ on 2026-03-20", "fx_date": "2026-03-20", "fx_note": "", "txt": "US$12m", "gbp_txt": "£9m", "show": true }, { "id": "DEAL-UG-006", "date": "2026-03-18", "year": "2026", "kind": "funding_round", "company_text": "Entourage AI (new)", "company_id": "BIZ-SU-HLT-402", "counterparty": "Provision", "amount": 5000000, "amount_text": "5000000", "currency": "USD", "valuation_reported": null, "summary": "Pre-seed round at launch, with GU Holdings.", "sources_text": "https://www.gla.ac.uk/news/archiveofnews/2026/march/headline_1254829_en.html — \"a longevity and healthspan focused data company\"", "source_urls": [ "https://www.gla.ac.uk/news/archiveofnews/2026/march/headline_1254829_en.html" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2026-03-18", "date_sort": "2026-03-18", "before_ledger_start": false, "amount_gbp": 3752909, "fx_rate": 1.3323, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.3323 per £ on 2026-03-18", "fx_date": "2026-03-18", "fx_note": "", "txt": "US$5m", "gbp_txt": "£3.8m", "show": true }, { "id": "DEAL-SU-HLT-010", "date": "2026-03-16", "year": "2026", "kind": "funding_round", "company_text": "Spotlight Pathology (BIZ-SU-HLT-012)", "company_id": "BIZ-SU-HLT-012", "counterparty": "UKI2S and Liverpool City Region Seed Fund", "amount": 1400000, "amount_text": "1400000", "currency": "GBP", "valuation_reported": null, "summary": "Seed round.", "sources_text": "https://htn.co.uk/2026/03/16/spotlight-pathology-secures-1-4-million-seed-investment-for-ai-blood-cancer-diagnostics/ — \"has secured £1.4 million in seed funding.\" (accessed 2026-10-29)", "source_urls": [ "https://htn.co.uk/2026/03/16/spotlight-pathology-secures-1-4-million-seed-investment-for-ai-blood-cancer-diagnostics/" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2026-03-16", "date_sort": "2026-03-16", "before_ledger_start": false, "amount_gbp": 1400000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.4m", "gbp_txt": "£1.4m", "show": true }, { "id": "DEAL-SU-HLT-011", "date": "2026-03-16", "year": "2026", "kind": "funding_round", "company_text": "Ternary Therapeutics (BIZ-SU-HLT-016)", "company_id": "BIZ-SU-HLT-016", "counterparty": "daphni", "amount": 3600000, "amount_text": "3600000", "currency": "GBP", "valuation_reported": null, "summary": "Seed round.", "sources_text": "https://www.uktech.news/medtech/biotech-building-molecular-glues-ai-platform-raises-3-6m-20260316 — \"has secured a £3.6m seed investment\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/biotech-building-molecular-glues-ai-platform-raises-3-6m-20260316" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2026-03-16", "date_sort": "2026-03-16", "before_ledger_start": false, "amount_gbp": 3600000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£3.6m", "gbp_txt": "£3.6m", "show": true }, { "id": "DEAL-LAB-12017", "date": "2026-03-10", "year": "2026", "kind": "partnership", "company_text": "Antiverse", "company_id": "BIZ-SU-HLT-013", "counterparty": "Cystic Fibrosis Foundation", "amount": null, "amount_text": "undisclosed", "currency": null, "valuation_reported": null, "summary": "Antiverse and the Cystic Fibrosis Foundation team up on antibodies For: Research agreement to develop new antibodies.", "sources_text": "https://www.antiverse.io/ — \"Research agreement with the Cystic Fibrosis Foundation\"; https://www.antiverse.io/news — \"Antiverse, Cystic Fibrosis Foundation team to develop new antibodies\"", "source_urls": [ "https://www.antiverse.io/", "https://www.antiverse.io/news" ], "confidence": "single_source", "ledger": "page", "page": "labs", "render": true, "date_text": "2026-03-10", "date_sort": "2026-03-10", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true, "labs_r8": true }, { "id": "DEAL-LAB-16013", "date": "2026-03-10", "year": "2026", "kind": "partnership", "company_text": "Antiverse", "company_id": "BIZ-SU-HLT-013", "counterparty": "Cystic Fibrosis Foundation", "amount": null, "amount_text": "undisclosed", "currency": null, "valuation_reported": null, "summary": "Antiverse and the Cystic Fibrosis Foundation agreed to develop new antibodies. For: antibodies against the extracellular region of CFTR.", "sources_text": "https://www.antiverse.io/news — \"Antiverse, Cystic Fibrosis Foundation team to develop new antibodies\"; https://tech.eu/2026/03/03/antiverse-secures-93m-series-a-for-ai-antibody-platform/ (trade)", "source_urls": [ "https://www.antiverse.io/news", "https://tech.eu/2026/03/03/antiverse-secures-93m-series-a-for-ai-antibody-platform/" ], "confidence": "verified", "ledger": "page", "page": "labs", "render": true, "date_text": "2026-03-10", "date_sort": "2026-03-10", "before_ledger_start": false, "week_ending": false, "trade": true, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true, "labs_r8": true }, { "id": "DEAL-INV-015", "date": "2026-03-03", "year": "2026", "kind": "funding_round", "company_text": "Antiverse (BIZ-SU-HLT-013)", "company_id": "BIZ-SU-HLT-013", "counterparty": "Development Bank of Wales (BIZ-INV-052); Innovation Investment Capital (BIZ-INV-053)", "amount": 9300000, "amount_text": "9300000", "currency": "USD", "valuation_reported": null, "summary": "Series A; DBW invested from Wales Technology Seed Fund II (amount not stated)", "sources_text": "https://developmentbank.wales/news-and-events/investors-back-antiverse-accelerate-ai-driven-drug-discovery-93-million-round — \"$9.3 million Series A funding round\"", "source_urls": [ "https://developmentbank.wales/news-and-events/investors-back-antiverse-accelerate-ai-driven-drug-discovery-93-million-round" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2026-03-03", "date_sort": "2026-03-03", "before_ledger_start": false, "amount_gbp": 6991430, "fx_rate": 1.3302, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.3302 per £ on 2026-03-03", "fx_date": "2026-03-03", "fx_note": "", "txt": "US$9.3m", "gbp_txt": "£7m", "show": true }, { "id": "DEAL-SU-HLT-012", "date": "2026-03-03", "year": "2026", "kind": "funding_round", "company_text": "Antiverse (BIZ-SU-HLT-013)", "company_id": "BIZ-SU-HLT-013", "counterparty": "Soulmates Ventures", "amount": 9300000, "amount_text": "9300000", "currency": "USD", "valuation_reported": null, "summary": "Series A for AI-designed antibodies.", "sources_text": "https://www.uktech.news/ai/welsh-biotech-raises-7m-for-ai-designed-antibodies-20260303 — $9.3m (£7m) Series A led by Soulmates Ventures (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/ai/welsh-biotech-raises-7m-for-ai-designed-antibodies-20260303" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "same_event_as": "DEAL-INV-015", "date_text": "2026-03-03", "date_sort": "2026-03-03", "before_ledger_start": false, "amount_gbp": 6991430, "fx_rate": 1.3302, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.3302 per £ on 2026-03-03", "fx_date": "2026-03-03", "fx_note": "", "txt": "US$9.3m", "gbp_txt": "£7m", "show": true }, { "id": "DEAL-UG-005", "date": "2026-03-02", "year": "2026", "kind": "funding_round", "company_text": "TileBio (new)", "company_id": "BIZ-SU-HLT-401", "counterparty": "Twin Path Ventures", "amount": 1600000, "amount_text": "1600000", "currency": "GBP", "valuation_reported": null, "summary": "Seed round at launch, with Scottish Enterprise and GU Holdings.", "sources_text": "https://www.gla.ac.uk/news/headline_1249369_en.html — \"led by Twin Path Ventures with participation from Scottish Enterprise\"", "source_urls": [ "https://www.gla.ac.uk/news/headline_1249369_en.html" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2026-03-02", "date_sort": "2026-03-02", "before_ledger_start": false, "amount_gbp": 1600000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.6m", "gbp_txt": "£1.6m", "show": true }, { "id": "DEAL-RG-005", "date": "2026-03", "year": "2026", "kind": "funding_round", "company_text": "Entourage AI (new) BIZ-SU-HLT-402", "company_id": "BIZ-SU-HLT-402", "counterparty": "Provision", "amount": 5000000, "amount_text": "5000000", "currency": "USD", "valuation_reported": null, "summary": "Pre-seed with GU Holdings and angels", "sources_text": "https://www.digit.fyi/digit-deal-roundup-march-2026/ — \"Using its proprietary platform to analyse thousands of human proteins\"", "source_urls": [ "https://www.digit.fyi/digit-deal-roundup-march-2026/" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2026-03", "date_sort": "2026-03-00", "before_ledger_start": false, "amount_gbp": 3719408, "fx_rate": 1.3443, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.3443 per £ on 2026-02-27", "fx_date": "2026-02-27", "fx_note": "month only given: rate for the 1st", "txt": "US$5m", "gbp_txt": "£3.7m", "show": true }, { "id": "DEAL-RG-006", "date": "2026-03", "year": "2026", "kind": "funding_round", "company_text": "TileBio (new) BIZ-SU-HLT-401", "company_id": "BIZ-SU-HLT-401", "counterparty": "Twin Path Ventures", "amount": 1600000, "amount_text": "1600000", "currency": "GBP", "valuation_reported": null, "summary": "Seed with Scottish Enterprise and GU Holdings", "sources_text": "https://www.digit.fyi/digit-deal-roundup-march-2026/ — \"AI technology that learns ‘the language of cancer’\"", "source_urls": [ "https://www.digit.fyi/digit-deal-roundup-march-2026/" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2026-03", "date_sort": "2026-03-00", "before_ledger_start": false, "amount_gbp": 1600000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.6m", "gbp_txt": "£1.6m", "show": true }, { "id": "DEAL-SU-HLT-013", "date": "2026-02-28", "year": "2026", "kind": "wind_down", "company_text": "Lenus Health (BIZ-SU-HLT-028)", "company_id": "BIZ-SU-HLT-028", "counterparty": null, "amount": null, "amount_text": null, "currency": null, "valuation_reported": null, "summary": "Dissolved after administration.", "sources_text": "https://find-and-update.company-information.service.gov.uk/company/SC652563 — \"Dissolved\" \"28 February 2026\" (accessed 2026-10-29)", "source_urls": [ "https://find-and-update.company-information.service.gov.uk/company/SC652563" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2026-02-28", "date_sort": "2026-02-28", "before_ledger_start": false, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-014", "date": "2026-02-24", "year": "2026", "kind": "funding_round", "company_text": "Brainomix (BIZ-SU-HLT-006)", "company_id": "BIZ-SU-HLT-006", "counterparty": "Parkwalk Advisors and Hostplus (IP Group Hostplus Innovation Fund)", "amount": 4800000, "amount_text": "4800000", "currency": "GBP", "valuation_reported": null, "summary": "Series C extension with Modi Ventures; round total £18.8m.", "sources_text": "https://www.uktech.news/medtech/brainomix-extends-series-c-with-new-5m-investment-20260224 — \"led by existing investors Parkwalk Advisors and Hostplus via the IP Group Hostplus Innovation Fund\"; https://htn.co.uk/2026/02/25/university-of-oxford-spinout-brainomix-takes-total-funding-to-18-8million-in-support-of-us-expansion/ — \"has successfully raised £18.8 million in Series C funding\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/brainomix-extends-series-c-with-new-5m-investment-20260224", "https://htn.co.uk/2026/02/25/university-of-oxford-spinout-brainomix-takes-total-funding-to-18-8million-in-support-of-us-expansion/" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2026-02-24", "date_sort": "2026-02-24", "before_ledger_start": false, "amount_gbp": 4800000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£4.8m", "gbp_txt": "£4.8m", "show": true }, { "id": "DEAL-INV-2065", "date": "2026-02-20", "year": "2026", "kind": "funding_round", "company_text": "Klaris", "company_id": "BIZ-SU-HLT-019", "counterparty": "Meridian Health Ventures", "amount": 730000, "amount_text": "730,000", "currency": "GBP", "valuation_reported": null, "summary": "Klaris (AI regulatory-approval tool) raised £730,000 (Pre-seed), reported by UKTN weekly roundup.", "sources_text": "https://www.uktech.news/funding/uk-tech-funding-roundup-this-weeks-deals-from-fyld-to-nul-20260220 — \"an AI tool to simplify the process of applying for regulatory approval\" (trade)", "source_urls": [ "https://www.uktech.news/funding/uk-tech-funding-roundup-this-weeks-deals-from-fyld-to-nul-20260220" ], "confidence": "single_source", "ledger": "page", "page": "investors", "render": true, "date_text": "2026-02-20 (week ending)", "date_sort": "2026-02-20", "before_ledger_start": false, "week_ending": true, "trade": true, "round4": true, "amount_gbp": 730000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£730,000", "gbp_txt": "£730,000", "show": true }, { "id": "DEAL-SU-HLT-015", "date": "2026-02-17", "year": "2026", "kind": "funding_round", "company_text": "Klaris (BIZ-SU-HLT-019)", "company_id": "BIZ-SU-HLT-019", "counterparty": "Meridian Health Ventures", "amount": 1000000, "amount_text": "1000000", "currency": "USD", "valuation_reported": null, "summary": "Pre-seed with Antler, Vento Ventures, Alecla7 and angels.", "sources_text": "https://www.uktech.news/medtech/klaris-medical-device-pre-seed-20260217 — \"The pre-seed funding round was led by Meridian Health Ventures.\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/klaris-medical-device-pre-seed-20260217" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2026-02-17", "date_sort": "2026-02-17", "before_ledger_start": false, "amount_gbp": 740576, "fx_rate": 1.3503, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.3503 per £ on 2026-02-17", "fx_date": "2026-02-17", "fx_note": "", "txt": "US$1m", "gbp_txt": "£740,576", "show": true }, { "id": "DEAL-SU-HLT-016", "date": "2026-01-22", "year": "2026", "kind": "rename", "company_text": "Kheiron Medical Technologies (BIZ-SU-HLT-004)", "company_id": "BIZ-SU-HLT-004", "counterparty": "DeepHealth UK Limited", "amount": null, "amount_text": null, "currency": null, "valuation_reported": null, "summary": "UK company renamed DeepHealth UK Limited.", "sources_text": "https://find-and-update.company-information.service.gov.uk/company/10184103 — \"KHEIRON MEDICAL TECHNOLOGIES LTD: 08 Jun 2016 to 22 Jan 2026\" (accessed 2026-10-29)", "source_urls": [ "https://find-and-update.company-information.service.gov.uk/company/10184103" ], "confidence": "verified", "ledger": "page", "page": "startups", "render": true, "date_text": "2026-01-22", "date_sort": "2026-01-22", "before_ledger_start": false, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-UG-004", "date": "2026", "year": "2026", "kind": "funding_round", "company_text": "Hypervision Surgical (new)", "company_id": "BIZ-SU-HLT-503", "counterparty": null, "amount": 17000000, "amount_text": "17000000", "currency": "GBP", "valuation_reported": null, "summary": "King's reports the spin-out \"recently raised £17 million\".", "sources_text": "https://www.kcl.ac.uk/news/ukri-leader-meets-kings-academics-and-entrepreneurs — \"Another King’s spinout, Hypervision surgical, also based at the LIHE\"", "source_urls": [ "https://www.kcl.ac.uk/news/ukri-leader-meets-kings-academics-and-entrepreneurs" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2026 (day not stated; reported 2026-09-25)", "date_sort": "2026-00-00", "before_ledger_start": false, "amount_gbp": 17000000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£17m", "gbp_txt": "£17m", "show": true }, { "id": "DEAL-LC-064", "date": "2025-12-03", "year": "2025", "kind": "funding_round", "company_text": "Revela (formerly Spotlight Health) (new)", "company_id": "BIZ-SU-HLT-706", "counterparty": "PXN Ventures (PraeSeed programme)", "amount": 200000, "amount_text": "200000", "currency": "GBP", "valuation_reported": null, "summary": "PraeSeed investment for AI analysis of ultrasound scans for endometriosis.", "sources_text": "https://businesscloud.co.uk/news/8-startups-funded-by-pxns-praeseed-programme/ — \"performing AI analysis on ultrasound scans to spot the subtle signs of a condition\" (trade, BusinessCloud)", "source_urls": [ "https://businesscloud.co.uk/news/8-startups-funded-by-pxns-praeseed-programme/" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2025-12-03", "date_sort": "2025-12-03", "before_ledger_start": false, "amount_gbp": 200000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£200,000", "gbp_txt": "£200,000", "show": true }, { "id": "DEAL-UG-002", "date": "2025-12-03", "year": "2025", "kind": "spin_out", "company_text": "CogStack (new)", "company_id": "BIZ-SU-HLT-505", "counterparty": "King's College London", "amount": null, "amount_text": null, "currency": null, "valuation_reported": null, "summary": "King's announces CogStack as a spin-out company.", "sources_text": "https://www.kcl.ac.uk/people/tom-searle — \"New spinout CogStack is unlocking the power of healthcare data through AI to transform clinical care\"", "source_urls": [ "https://www.kcl.ac.uk/people/tom-searle" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2025-12-03", "date_sort": "2025-12-03", "before_ledger_start": false, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-017", "date": "2025-10-13", "year": "2025", "kind": "funding_round", "company_text": "Gladys (BIZ-SU-HLT-017)", "company_id": "BIZ-SU-HLT-017", "counterparty": "Cornerstone VC", "amount": 1500000, "amount_text": "1500000", "currency": "GBP", "valuation_reported": null, "summary": "Seed round.", "sources_text": "https://www.uktech.news/medtech/gladys-1-5m-ai-home-care-20251013 — \"a seed funding round worth £1.5m\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/gladys-1-5m-ai-home-care-20251013" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2025-10-13", "date_sort": "2025-10-13", "before_ledger_start": false, "amount_gbp": 1500000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.5m", "gbp_txt": "£1.5m", "show": true }, { "id": "DEAL-SU-HLT-018", "date": "2025-10-03", "year": "2025", "kind": "funding_round", "company_text": "Simple Life (BIZ-SU-HLT-044)", "company_id": "BIZ-SU-HLT-044", "counterparty": "HartBeat Ventures (co-lead)", "amount": 26000000, "amount_text": "26000000", "currency": "GBP", "valuation_reported": null, "summary": "Round with Liquidity.", "sources_text": "https://www.uktech.news/medtech/kevin-harts-vc-fund-leads-26m-round-for-ai-health-app-20251003 — \"has co-led a £26m investment in London-based health and fitness app Simple Life.\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/kevin-harts-vc-fund-leads-26m-round-for-ai-health-app-20251003" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2025-10-03", "date_sort": "2025-10-03", "before_ledger_start": false, "amount_gbp": 26000000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£26m", "gbp_txt": "£26m", "show": true }, { "id": "DEAL-INV-2079", "date": "2025-10-03", "year": "2025", "kind": "funding_round", "company_text": "Simple Life", "company_id": "BIZ-SU-HLT-044", "counterparty": "HartBeat Ventures, Liquidity", "amount": null, "amount_text": "26m", "currency": "GBP", "valuation_reported": null, "summary": "Simple Life (health app with generative AI assistant) raised £26m (Series A), reported by UKTN weekly roundup.", "sources_text": "https://www.uktech.news/funding/uk-tech-funding-roundup-this-weeks-deals-from-nscale-to-chalkie-20251003 — \"a health and fitness app featuring a generative AI assistant\" (trade)", "source_urls": [ "https://www.uktech.news/funding/uk-tech-funding-roundup-this-weeks-deals-from-nscale-to-chalkie-20251003" ], "confidence": "single_source", "ledger": "page", "page": "investors", "render": true, "date_text": "2025-10-03 (week ending)", "date_sort": "2025-10-03", "before_ledger_start": false, "week_ending": true, "trade": true, "round4": true, "amount_as_written": "26m", "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "26m GBP", "gbp_txt": "", "show": true }, { "id": "DEAL-INV-2087", "date": "2025-08-01", "year": "2025", "kind": "funding_round", "company_text": "Ultromics", "company_id": "BIZ-SU-HLT-007", "counterparty": "L&G, Allegis Capital, Lightrock, University of Chicago Medicine and others", "amount": null, "amount_text": "41.4m", "currency": "GBP", "valuation_reported": null, "summary": "Ultromics (AI heart diagnostics) raised £41.4m (Series C), reported by UKTN weekly roundup.", "sources_text": "https://www.uktech.news/funding/uk-tech-funding-roundup-this-weeks-deals-from-ultromics-to-fluid-focus-20250801 — \"develops AI cardiology diagnostics technology\" (trade)", "source_urls": [ "https://www.uktech.news/funding/uk-tech-funding-roundup-this-weeks-deals-from-ultromics-to-fluid-focus-20250801" ], "confidence": "single_source", "ledger": "page", "page": "investors", "render": true, "date_text": "2025-08-01 (week ending)", "date_sort": "2025-08-01", "before_ledger_start": false, "week_ending": true, "trade": true, "round4": true, "amount_as_written": "41.4m", "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "41.4m GBP", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-019", "date": "2025-07-31", "year": "2025", "kind": "funding_round", "company_text": "Ultromics (BIZ-SU-HLT-007)", "company_id": "BIZ-SU-HLT-007", "counterparty": "L&G, Allegis Capital, Lightrock", "amount": 55000000, "amount_text": "55000000", "currency": "USD", "valuation_reported": null, "summary": "Series C for US expansion.", "sources_text": "https://www.uktech.news/medtech/ai-cardiology-group-ultromics-gears-up-for-us-growth-with-40m-round-20250731 — \"was led by L&G, Allegis Capital and Lightrock\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/ai-cardiology-group-ultromics-gears-up-for-us-growth-with-40m-round-20250731" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2025-07-31", "date_sort": "2025-07-31", "before_ledger_start": false, "amount_gbp": 41565901, "fx_rate": 1.3232, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.3232 per £ on 2025-07-31", "fx_date": "2025-07-31", "fx_note": "", "txt": "US$55m", "gbp_txt": "£41.6m", "show": true }, { "id": "DEAL-LC-030", "date": "2025-07-09", "year": "2025", "kind": "funding_round", "company_text": "ScienceMachine (new)", "company_id": "BIZ-SU-HLT-807", "counterparty": "Revent; Nucleus Capital (leads); angels", "amount": 3500000, "amount_text": "3500000", "currency": "USD", "valuation_reported": null, "summary": "Pre-seed for an autonomous AI agent that analyses biotech data.", "sources_text": "https://tech.eu/2025/07/09/sciencemachine-raises-35m-for-leading-autonomous-ai-in-biotech-research/ — \"has raised a $3.5 million pre-seed funding round.\" (trade, tech.eu)", "source_urls": [ "https://tech.eu/2025/07/09/sciencemachine-raises-35m-for-leading-autonomous-ai-in-biotech-research/" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2025-07-09", "date_sort": "2025-07-09", "before_ledger_start": false, "amount_gbp": 2575802, "fx_rate": 1.3588, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.3588 per £ on 2025-07-09", "fx_date": "2025-07-09", "fx_note": "", "txt": "US$3.5m", "gbp_txt": "£2.6m", "show": true }, { "id": "DEAL-SU-HLT-2041", "date": "2025-07-09", "year": "2025", "kind": "grant", "company_text": "Lucida Medical", "company_id": "BIZ-SU-HLT-011", "counterparty": "SBRI Healthcare / NHS Cancer Programme", "amount": 2252379, "amount_text": "2252379", "currency": "GBP", "valuation_reported": null, "summary": "NHS Cancer Programme award for Pi, AI software that analyses prostate MRI scans.", "sources_text": "https://sbrihealthcare.co.uk/news/nhs-cancer-programme-awards-14-4-million-to-accelerate-new-front-line-innovations-that-detect-and-diagnose-cancer-earlier — \"Pi™ is AI-based medical software that automatically analyses MRI scans for prostate cancer\"", "source_urls": [ "https://sbrihealthcare.co.uk/news/nhs-cancer-programme-awards-14-4-million-to-accelerate-new-front-line-innovations-that-detect-and-diagnose-cancer-earlier" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2025-07-09", "date_sort": "2025-07-09", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": 2252379, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£2.3m", "gbp_txt": "£2.3m", "show": true }, { "id": "DEAL-SU-HLT-2042", "date": "2025-07-09", "year": "2025", "kind": "grant", "company_text": "Optellum", "company_id": "BIZ-SU-HLT-040", "counterparty": "Guy's and St Thomas' NHS Foundation Trust (lead) / NHS Cancer Programme", "amount": 2254634, "amount_text": "2254634", "currency": "GBP", "valuation_reported": null, "summary": "Trust-led award combining Optellum AI nodule risk stratification with robotic bronchoscopy.", "sources_text": "https://sbrihealthcare.co.uk/news/nhs-cancer-programme-awards-14-4-million-to-accelerate-new-front-line-innovations-that-detect-and-diagnose-cancer-earlier — \"A new diagnostic pathway combining AI-powered nodule risk stratification (Optellum) with robotic bronchoscopy\"", "source_urls": [ "https://sbrihealthcare.co.uk/news/nhs-cancer-programme-awards-14-4-million-to-accelerate-new-front-line-innovations-that-detect-and-diagnose-cancer-earlier" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2025-07-09", "date_sort": "2025-07-09", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": 2254634, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£2.3m", "gbp_txt": "£2.3m", "show": true }, { "id": "DEAL-INV-2113", "date": "2025-07-09", "year": "2025", "kind": "funding_round", "company_text": "ScienceMachine", "company_id": "BIZ-SU-HLT-807", "counterparty": "Revent, Nucleus Capital", "amount": null, "amount_text": "3.5m", "currency": "USD", "valuation_reported": null, "summary": "ScienceMachine (autonomous AI bioinformatics agent) raised $3.5m (Pre-seed), reported by tech.eu.", "sources_text": "https://tech.eu/2025/07/09/sciencemachine-raises-35m-for-leading-autonomous-ai-in-biotech-research/ — \"functions as a 24/7 AI bioinformatician\" (trade)", "source_urls": [ "https://tech.eu/2025/07/09/sciencemachine-raises-35m-for-leading-autonomous-ai-in-biotech-research/" ], "confidence": "single_source", "ledger": "page", "page": "investors", "render": true, "date_text": "2025-07-09", "date_sort": "2025-07-09", "before_ledger_start": false, "week_ending": false, "trade": true, "round4": true, "amount_as_written": "3.5m", "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "3.5m USD", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-020", "date": "2025-06-27", "year": "2025", "kind": "funding_round", "company_text": "Elyndra (BIZ-SU-HLT-046)", "company_id": "BIZ-SU-HLT-046", "counterparty": "Outward VC", "amount": 1100000, "amount_text": "1100000", "currency": "GBP", "valuation_reported": null, "summary": "Investment round.", "sources_text": "https://www.uktech.news/medtech/social-care-platform-elyndra-scores-1-1m-20250627 — \"has secured a £1.1m investment led by Outward VC.\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/social-care-platform-elyndra-scores-1-1m-20250627" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2025-06-27", "date_sort": "2025-06-27", "before_ledger_start": false, "amount_gbp": 1100000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.1m", "gbp_txt": "£1.1m", "show": true }, { "id": "DEAL-SU-HLT-021", "date": "2025-06-24", "year": "2025", "kind": "funding_round", "company_text": "OutSee (BIZ-SU-HLT-023)", "company_id": "BIZ-SU-HLT-023", "counterparty": "Ahren Innovation Capital", "amount": 1800000, "amount_text": "1800000", "currency": "GBP", "valuation_reported": null, "summary": "Seed round.", "sources_text": "https://www.uktech.news/medtech/outsee-raises-1-8m-seed-funding-20250624 — £1.8m seed led by Ahren Innovation Capital (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/outsee-raises-1-8m-seed-funding-20250624" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2025-06-24", "date_sort": "2025-06-24", "before_ledger_start": false, "amount_gbp": 1800000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.8m", "gbp_txt": "£1.8m", "show": true }, { "id": "DEAL-LAB-16020", "date": "2025-06-13", "year": "2025", "kind": "partnership", "company_text": "Kuano", "company_id": "BIZ-SU-HLT-055", "counterparty": "University of Bristol (Mulholland group)", "amount": null, "amount_text": "undisclosed", "currency": null, "valuation_reported": null, "summary": "Kuano published results of its IRAP collaboration with Bristol. For: quantum simulation of IRAP enzyme inhibition.", "sources_text": "https://www.kuano.ai/news — \"the publication of the results from our collaboration with the Mulholland group at the University of Bristol\"", "source_urls": [ "https://www.kuano.ai/news" ], "confidence": "single_source", "ledger": "page", "page": "labs", "render": true, "date_text": "2025-06-13", "date_sort": "2025-06-13", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true, "labs_r8": true }, { "id": "DEAL-LAB-12016", "date": "2025-06-12", "year": "2025", "kind": "partnership", "company_text": "Peptone", "company_id": "BIZ-SU-HLT-065", "counterparty": "NVIDIA", "amount": null, "amount_text": null, "currency": null, "valuation_reported": null, "summary": "Peptone and NVIDIA release PepTron-o For: Co-introduced PepTron-o structure-prediction model.", "sources_text": "https://peptone.io/news/ — \"Peptone and NVIDIA introduce PepTron-o for ensemble-first structure prediction of the disordered proteome\"", "source_urls": [ "https://peptone.io/news/" ], "confidence": "single_source", "ledger": "page", "page": "labs", "render": true, "date_text": "2025-06-12", "date_sort": "2025-06-12", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true, "labs_r8": true }, { "id": "DEAL-SU-HLT-022", "date": "2025-06-05", "year": "2025", "kind": "funding_round", "company_text": "Kiin Bio (BIZ-SU-HLT-022)", "company_id": "BIZ-SU-HLT-022", "counterparty": "b2venture", "amount": 1600000, "amount_text": "1600000", "currency": "GBP", "valuation_reported": null, "summary": "Pre-seed.", "sources_text": "https://www.uktech.news/medtech/ai-drug-discovery-startup-kiin-bio-secures-pre-seed-funding-20250605 — \"has secured a pre-seed investment of £1.6m.\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/ai-drug-discovery-startup-kiin-bio-secures-pre-seed-funding-20250605" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2025-06-05", "date_sort": "2025-06-05", "before_ledger_start": false, "amount_gbp": 1600000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.6m", "gbp_txt": "£1.6m", "show": true }, { "id": "DEAL-LAB-12015", "date": "2025-05-08", "year": "2025", "kind": "partnership", "company_text": "Peptone", "company_id": "BIZ-SU-HLT-065", "counterparty": "Evotec", "amount": null, "amount_text": "undisclosed", "currency": null, "valuation_reported": null, "summary": "Peptone and Evotec form a strategic partnership For: Small molecules against intrinsically disordered proteins.", "sources_text": "https://peptone.io/news/ — \"Peptone and Evotec form strategic partnership to target intrinsically disordered proteins\"", "source_urls": [ "https://peptone.io/news/" ], "confidence": "single_source", "ledger": "page", "page": "labs", "render": true, "date_text": "2025-05-08", "date_sort": "2025-05-08", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true, "labs_r8": true }, { "id": "DEAL-LAB-2013", "date": "2025-05-01", "year": "2025", "kind": "funding_round", "company_text": "AMPLY Discovery", "company_id": "BIZ-SU-HLT-048", "counterparty": "Twin Path Ventures", "amount": 1750000, "amount_text": "1,750,000", "currency": "USD", "valuation_reported": null, "summary": "Seed round for Queen's University Belfast spin-out.", "sources_text": "https://tech.eu/2025/05/01/queens-university-spin-off-amply-secures-175m-for-ai-drug-discovery/", "source_urls": [ "https://tech.eu/2025/05/01/queens-university-spin-off-amply-secures-175m-for-ai-drug-discovery/" ], "confidence": "single_source", "ledger": "page", "page": "labs", "render": true, "date_text": "2025-05-01", "date_sort": "2025-05-01", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": 1316185, "fx_rate": 1.3296, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.3296 per £ on 2025-05-01", "fx_date": "2025-05-01", "fx_note": "", "txt": "US$1.8m", "gbp_txt": "£1.3m", "show": true }, { "id": "DEAL-SU-HLT-2016", "date": "2025-03-31", "year": "2025", "kind": "grant", "company_text": "InsideOut 25", "company_id": "BIZ-SU-HLT-2024", "counterparty": "SBRI Healthcare", "amount": 196071, "amount_text": "196071", "currency": "GBP", "valuation_reported": null, "summary": "SBRI award for AI avatar-led workplace mental health interventions.", "sources_text": "https://sbrihealthcare.co.uk/news/sbri-healthcare-funding-awarded-to-work-related-digital-innovations-for-individuals-with-poor-mental-health — \"Using AI Avatar-led Mental Health Interventions for keeping employees in work.\"", "source_urls": [ "https://sbrihealthcare.co.uk/news/sbri-healthcare-funding-awarded-to-work-related-digital-innovations-for-individuals-with-poor-mental-health" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2025-03-31", "date_sort": "2025-03-31", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": 196071, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£196,071", "gbp_txt": "£196,071", "show": true }, { "id": "DEAL-SU-HLT-2017", "date": "2025-03-31", "year": "2025", "kind": "grant", "company_text": "Affiniti AI", "company_id": "BIZ-SU-HLT-2025", "counterparty": "SBRI Healthcare", "amount": 194852, "amount_text": "194852", "currency": "GBP", "valuation_reported": null, "summary": "SBRI award for AI mental health co-therapist.", "sources_text": "https://sbrihealthcare.co.uk/news/sbri-healthcare-funding-awarded-to-work-related-digital-innovations-for-individuals-with-poor-mental-health — \"a personalised mental health co-therapist that supports patients between therapy sessions.\"", "source_urls": [ "https://sbrihealthcare.co.uk/news/sbri-healthcare-funding-awarded-to-work-related-digital-innovations-for-individuals-with-poor-mental-health" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2025-03-31", "date_sort": "2025-03-31", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": 194852, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£194,852", "gbp_txt": "£194,852", "show": true }, { "id": "DEAL-SU-HLT-2022", "date": "2025-03-18", "year": "2025", "kind": "grant", "company_text": "CareLoop Health", "company_id": "BIZ-SU-HLT-2030", "counterparty": "SBRI Healthcare (Competition 26, urgent and emergency care phase 3)", "amount": 488002, "amount_text": "488002", "currency": "GBP", "valuation_reported": null, "summary": "SBRI phase 3 award for AI digital therapeutic platform.", "sources_text": "https://sbrihealthcare.co.uk/news/funding-awarded-to-innovations-that-support-the-delivery-of-urgent-emergency-care — \"Using a smartphone, patients give regular feedback and access self-management tools.\"", "source_urls": [ "https://sbrihealthcare.co.uk/news/funding-awarded-to-innovations-that-support-the-delivery-of-urgent-emergency-care" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2025-03-18", "date_sort": "2025-03-18", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": 488002, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£488,002", "gbp_txt": "£488,002", "show": true }, { "id": "DEAL-SU-HLT-2023", "date": "2025-03-18", "year": "2025", "kind": "grant", "company_text": "Bering", "company_id": "BIZ-SU-HLT-2031", "counterparty": "SBRI Healthcare (Competition 26, urgent and emergency care phase 3)", "amount": 499258, "amount_text": "499258", "currency": "GBP", "valuation_reported": null, "summary": "SBRI phase 3 award for machine-learning admission-risk tool.", "sources_text": "https://sbrihealthcare.co.uk/news/funding-awarded-to-innovations-that-support-the-delivery-of-urgent-emergency-care — \"digital tool for early identification of individuals that may be at risk of unplanned hospital admissions\"", "source_urls": [ "https://sbrihealthcare.co.uk/news/funding-awarded-to-innovations-that-support-the-delivery-of-urgent-emergency-care" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2025-03-18", "date_sort": "2025-03-18", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": 499258, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£499,258", "gbp_txt": "£499,258", "show": true }, { "id": "DEAL-SU-HLT-2024", "date": "2025-03-18", "year": "2025", "kind": "grant", "company_text": "Dem Dx", "company_id": "BIZ-SU-HLT-2010", "counterparty": "SBRI Healthcare (Competition 26, urgent and emergency care phase 3)", "amount": 497234, "amount_text": "497234", "currency": "GBP", "valuation_reported": null, "summary": "SBRI phase 3 award for DemDx clinical decision platform for frontline clinicians.", "sources_text": "https://sbrihealthcare.co.uk/news/funding-awarded-to-innovations-that-support-the-delivery-of-urgent-emergency-care — \"DemDx enables frontline clinicians such as nurses, paramedics, physician associates, and pharmacists\"", "source_urls": [ "https://sbrihealthcare.co.uk/news/funding-awarded-to-innovations-that-support-the-delivery-of-urgent-emergency-care" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2025-03-18", "date_sort": "2025-03-18", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": 497234, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£497,234", "gbp_txt": "£497,234", "show": true }, { "id": "DEAL-X-008", "date": "2025-03-13", "year": "2025", "kind": "delisting", "company_text": "BenevolentAI (biz-benevolentai)", "company_id": "BIZ-SU-HLT-002", "counterparty": "Osaka Holdings S.à r.l.", "amount": null, "amount_text": null, "currency": null, "valuation_reported": null, "summary": "BenevolentAI shares were delisted from Euronext Amsterdam, following shareholder approval of a merger into Osaka Holdings (proposal published 5 February 2025).", "sources_text": "https://www.businesswire.com/news/home/20250312584164/en (company release) — \"BenevolentAI shares will be delisted from Euronext Amsterdam effective 13 March 2025.\"", "source_urls": [ "https://www.businesswire.com/news/home/20250312584164/en" ], "confidence": "single_source", "ledger": "sitewide", "page": "startups", "render": true, "date_text": "2025-03-13", "date_sort": "2025-03-13", "before_ledger_start": false, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-023", "date": "2025-03-13", "year": "2025", "kind": "delisting", "company_text": "BenevolentAI (BIZ-SU-HLT-002)", "company_id": "BIZ-SU-HLT-002", "counterparty": "Euronext Amsterdam", "amount": null, "amount_text": null, "currency": null, "valuation_reported": null, "summary": "Shares delisted from Euronext Amsterdam.", "sources_text": "https://www.businesswire.com/news/home/20250312584164/en — \"BenevolentAI shares will be delisted from Euronext Amsterdam effective 13 March 2025.\" (accessed 2026-10-29)", "source_urls": [ "https://www.businesswire.com/news/home/20250312584164/en" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "same_event_as": "DEAL-X-008", "date_text": "2025-03-13", "date_sort": "2025-03-13", "before_ledger_start": false, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-024", "date": "2025-03-12", "year": "2025", "kind": "merger", "company_text": "BenevolentAI (BIZ-SU-HLT-002)", "company_id": "BIZ-SU-HLT-002", "counterparty": "Osaka Holdings S.à r.l.", "amount": null, "amount_text": null, "currency": null, "valuation_reported": null, "summary": "Merged into Osaka Holdings, which took the BenevolentAI name.", "sources_text": "https://www.businesswire.com/news/home/20250312584164/en — \"Effective immediately, BenevolentAI has merged into Osaka Holdings S.à r.l.\" (accessed 2026-10-29)", "source_urls": [ "https://www.businesswire.com/news/home/20250312584164/en" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2025-03-12", "date_sort": "2025-03-12", "before_ledger_start": false, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-2020", "date": "2025-02-20", "year": "2025", "kind": "grant", "company_text": "Lighthearted AI Health", "company_id": "BIZ-SU-HLT-2028", "counterparty": "SBRI Healthcare (Competition 25, women's health phase 1)", "amount": 99125, "amount_text": "99125", "currency": "GBP", "valuation_reported": null, "summary": "SBRI phase 1 award for LightScope AI-assisted diagnosis.", "sources_text": "https://sbrihealthcare.co.uk/news/sbri-healthcare-funding-awarded-to-innovations-that-improve-women-s-health — \"LightScope uses laser light to capture high-precision bio-vitals and deliver accurate AI-assisted diagnosis\"", "source_urls": [ "https://sbrihealthcare.co.uk/news/sbri-healthcare-funding-awarded-to-innovations-that-improve-women-s-health" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2025-02-20", "date_sort": "2025-02-20", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": 99125, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£99,125", "gbp_txt": "£99,125", "show": true }, { "id": "DEAL-SU-HLT-2021", "date": "2025-02-20", "year": "2025", "kind": "grant", "company_text": "Spryt", "company_id": "BIZ-SU-HLT-2029", "counterparty": "SBRI Healthcare (Competition 25, women's health phase 1)", "amount": 100000, "amount_text": "100000", "currency": "GBP", "valuation_reported": null, "summary": "SBRI phase 1 award for Asa WhatsApp AI receptionist.", "sources_text": "https://sbrihealthcare.co.uk/news/sbri-healthcare-funding-awarded-to-innovations-that-improve-women-s-health — \"Asa is an AI receptionist that enables patients to book, cancel or reschedule medical appointments via WhatsApp\"", "source_urls": [ "https://sbrihealthcare.co.uk/news/sbri-healthcare-funding-awarded-to-innovations-that-improve-women-s-health" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2025-02-20", "date_sort": "2025-02-20", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": 100000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£100,000", "gbp_txt": "£100,000", "show": true }, { "id": "DEAL-SU-HLT-2043", "date": "2025-02-20", "year": "2025", "kind": "grant", "company_text": "Holly Health", "company_id": "BIZ-SU-HLT-054", "counterparty": "SBRI Healthcare (Competition 25, women's health phase 1)", "amount": 79247, "amount_text": "79247", "currency": "GBP", "valuation_reported": null, "summary": "SBRI phase 1 award to co-design coaching for binge eating symptoms.", "sources_text": "https://sbrihealthcare.co.uk/news/sbri-healthcare-funding-awarded-to-innovations-that-improve-women-s-health — \"The project will involve the co-design of a custom coaching experience to tackle binge eating symptoms\"", "source_urls": [ "https://sbrihealthcare.co.uk/news/sbri-healthcare-funding-awarded-to-innovations-that-improve-women-s-health" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2025-02-20", "date_sort": "2025-02-20", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": 79247, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£79,247", "gbp_txt": "£79,247", "show": true }, { "id": "DEAL-SU-HLT-071", "date": "2025-01-21", "year": "2025", "kind": "wind_down", "company_text": "Behold.ai (BIZ-SU-HLT-067)", "company_id": "BIZ-SU-HLT-067", "counterparty": "Court (compulsory liquidation)", "amount": null, "amount_text": null, "currency": null, "valuation_reported": null, "summary": "Court order to wind up filed 21 January 2025; liquidator appointed (filed 26 March 2025)", "sources_text": "https://find-and-update.company-information.service.gov.uk/company/10903206/filing-history — \"Order of court\" to wind up … \"Appointment of a liquidator\" (accessed 2026-10-29)", "source_urls": [ "https://find-and-update.company-information.service.gov.uk/company/10903206/filing-history" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2025-01-21", "date_sort": "2025-01-21", "before_ledger_start": false, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-LC-001", "date": "2025-01-10", "year": "2025", "kind": "funding_round", "company_text": "VitVio (new)", "company_id": "BIZ-SU-HLT-707", "counterparty": "LDV Capital, Bek Ventures, Tiny Supercomputer Investment Company and angels", "amount": 1500000, "amount_text": "1500000", "currency": "GBP", "valuation_reported": null, "summary": "Pre-seed for computer vision that tracks the performance of medical procedures.", "sources_text": "https://www.uktech.news/funding/uk-tech-funding-roundup-this-weeks-deals-from-verdiva-to-robok-20250110 — \"VitVio – £1.5m\" (trade, UKTN)", "source_urls": [ "https://www.uktech.news/funding/uk-tech-funding-roundup-this-weeks-deals-from-verdiva-to-robok-20250110" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2025-01-10", "date_sort": "2025-01-10", "before_ledger_start": false, "amount_gbp": 1500000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.5m", "gbp_txt": "£1.5m", "show": true }, { "id": "DEAL-SU-HLT-025", "date": "2025-01-09", "year": "2025", "kind": "collapse", "company_text": "Lenus Health (BIZ-SU-HLT-028)", "company_id": "BIZ-SU-HLT-028", "counterparty": "FRP Advisory (administrators)", "amount": null, "amount_text": null, "currency": null, "valuation_reported": null, "summary": "Administrator appointed.", "sources_text": "https://find-and-update.company-information.service.gov.uk/company/SC652563/filing-history — \"Appointment of an administrator\" (09 Jan 2025) (accessed 2026-10-29)", "source_urls": [ "https://find-and-update.company-information.service.gov.uk/company/SC652563/filing-history" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2025-01-09", "date_sort": "2025-01-09", "before_ledger_start": false, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-026", "date": "2025", "year": "2025", "kind": "funding_round", "company_text": "Brainomix (BIZ-SU-HLT-006)", "company_id": "BIZ-SU-HLT-006", "counterparty": "Parkwalk Advisors; Boehringer Ingelheim Venture Fund; Hostplus (as recorded in earlier pass)", "amount": 14000000, "amount_text": "14000000", "currency": "GBP", "valuation_reported": null, "summary": "Original Series C (year only).", "sources_text": "https://www.uktech.news/medtech/brainomix-extends-series-c-with-new-5m-investment-20260224 — Series C originally £14m, \"has now reached £18.8m\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/brainomix-extends-series-c-with-new-5m-investment-20260224" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2025", "date_sort": "2025-00-00", "before_ledger_start": false, "amount_gbp": 14000000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£14m", "gbp_txt": "£14m", "show": true }, { "id": "DEAL-SU-HLT-027", "date": "2025", "year": "2025", "kind": "funding_round", "company_text": "Ignota Labs (BIZ-SU-HLT-021)", "company_id": "BIZ-SU-HLT-021", "counterparty": null, "amount": 5500000, "amount_text": "5500000", "currency": "GBP", "valuation_reported": null, "summary": "Seed round (year only, as reported).", "sources_text": "https://www.businessweekly.co.uk/posts/honour-for-cso-maintains-upward-trajectory-for-ignota-labs — \"a seed raise of £5.5 million earlier this year\" (accessed 2026-10-29)", "source_urls": [ "https://www.businessweekly.co.uk/posts/honour-for-cso-maintains-upward-trajectory-for-ignota-labs" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2025", "date_sort": "2025-00-00", "before_ledger_start": false, "amount_gbp": 5500000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£5.5m", "gbp_txt": "£5.5m", "show": true }, { "id": "DEAL-SU-HLT-028", "date": "2025", "year": "2025", "kind": "funding_round", "company_text": "CHARM Therapeutics (BIZ-SU-HLT-027)", "company_id": "BIZ-SU-HLT-027", "counterparty": null, "amount": 80000000, "amount_text": "80000000", "currency": "USD", "valuation_reported": null, "summary": "Reported in Business Weekly's Q3 2025 Cambridge round-up; investors not stated.", "sources_text": "https://www.businessweekly.co.uk/posts/cambridge-life-sciences-fundraisings-pass-700m-as-q3-maintains-strong-momentum — CHARM Therapeutics $80.0 million (accessed 2026-10-29)", "source_urls": [ "https://www.businessweekly.co.uk/posts/cambridge-life-sciences-fundraisings-pass-700m-as-q3-maintains-strong-momentum" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2025", "date_sort": "2025-00-00", "before_ledger_start": false, "amount_gbp": 63851864, "fx_rate": 1.2529, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.2529 per £ on 2024-12-31", "fx_date": "2024-12-31", "fx_note": "year only given: rate for 1 January", "txt": "US$80m", "gbp_txt": "£63.9m", "show": true }, { "id": "DEAL-SU-HLT-029", "date": "2024-12-16", "year": "2024", "kind": "funding_round", "company_text": "Concinnity Genetics (BIZ-SU-HLT-045)", "company_id": "BIZ-SU-HLT-045", "counterparty": "Eos Advisory", "amount": 3000000, "amount_text": "3000000", "currency": "GBP", "valuation_reported": null, "summary": "Round with Scottish Enterprise, Old College Capital and Maven.", "sources_text": "https://www.uktech.news/medtech/edinburgh-health-tech-spinout-concinnity-genetics-raises-3m-20241216 — £3m led by Eos Advisory (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/edinburgh-health-tech-spinout-concinnity-genetics-raises-3m-20241216" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2024-12-16", "date_sort": "2024-12-16", "before_ledger_start": false, "amount_gbp": 3000000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£3m", "gbp_txt": "£3m", "show": true }, { "id": "DEAL-X-004", "date": "2024-11-20", "year": "2024", "kind": "merger", "company_text": "Exscientia (biz-exscientia)", "company_id": "BIZ-SU-HLT-003", "counterparty": "Recursion Pharmaceuticals", "amount": null, "amount_text": null, "currency": null, "valuation_reported": null, "summary": "Exscientia, the Oxford AI drug-discovery company, became a wholly owned subsidiary of Recursion on completion of their combination. Date is the completion date; value and announcement date not on the page opened.", "sources_text": "https://www.sec.gov/Archives/edgar/data/1865408/000094787124000937/ss4137056_ex9901.htm — \"has been completed, with Exscientia becoming a wholly owned subsidiary of Recursion\"", "source_urls": [ "https://www.sec.gov/Archives/edgar/data/1865408/000094787124000937/ss4137056_ex9901.htm" ], "confidence": "single_source", "ledger": "sitewide", "page": "startups", "render": true, "date_text": "2024-11-20", "date_sort": "2024-11-20", "before_ledger_start": false, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-030", "date": "2024-11-20", "year": "2024", "kind": "acquisition", "company_text": "Exscientia (BIZ-SU-HLT-003)", "company_id": "BIZ-SU-HLT-003", "counterparty": "Recursion Pharmaceuticals", "amount": null, "amount_text": null, "currency": null, "valuation_reported": null, "summary": "Business combination completed; Exscientia became a wholly owned subsidiary of Recursion.", "sources_text": "https://ir.recursion.com/news-releases/news-release-details/recursion-and-exscientia-two-leaders-ai-drug-discovery-space — \"has been completed, with Exscientia becoming a wholly owned subsidiary of Recursion\"; https://find-and-update.company-information.service.gov.uk/company/13483814 — \"EXSCIENTIA PLC (22 Sep 2021 to 16 Dec 2024)\" (accessed 2026-10-29)", "source_urls": [ "https://ir.recursion.com/news-releases/news-release-details/recursion-and-exscientia-two-leaders-ai-drug-discovery-space", "https://find-and-update.company-information.service.gov.uk/company/13483814" ], "confidence": "verified", "ledger": "page", "page": "startups", "render": true, "date_text": "2024-11-20", "date_sort": "2024-11-20", "before_ledger_start": false, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-031", "date": "2024-11-20", "year": "2024", "kind": "delisting", "company_text": "Exscientia (BIZ-SU-HLT-003)", "company_id": "BIZ-SU-HLT-003", "counterparty": "Nasdaq", "amount": null, "amount_text": null, "currency": null, "valuation_reported": null, "summary": "Nasdaq ADSs ceased trading and were to be delisted.", "sources_text": "https://ir.recursion.com/news-releases/news-release-details/recursion-and-exscientia-two-leaders-ai-drug-discovery-space — \"Exscientia ADSs (Nasdaq: EXAI) ceased trading and will be delisted from Nasdaq.\" (accessed 2026-10-29)", "source_urls": [ "https://ir.recursion.com/news-releases/news-release-details/recursion-and-exscientia-two-leaders-ai-drug-discovery-space" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2024-11-20", "date_sort": "2024-11-20", "before_ledger_start": false, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-032", "date": "2024-10-31", "year": "2024", "kind": "funding_round", "company_text": "Scalpel AI (BIZ-SU-HLT-024)", "company_id": "BIZ-SU-HLT-024", "counterparty": "Mercia Ventures", "amount": 3800000, "amount_text": "3800000", "currency": "GBP", "valuation_reported": null, "summary": "Round with Tensor Ventures.", "sources_text": "https://www.uktech.news/medtech/ai-surgery-startup-scalpel-raises-3-8m-20241031 — \"The funding round was led by Mercia Ventures\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/ai-surgery-startup-scalpel-raises-3-8m-20241031" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2024-10-31", "date_sort": "2024-10-31", "before_ledger_start": false, "amount_gbp": 3800000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£3.8m", "gbp_txt": "£3.8m", "show": true }, { "id": "DEAL-SU-HLT-033", "date": "2024-10-25", "year": "2024", "kind": "acquisition", "company_text": "Kheiron Medical Technologies (BIZ-SU-HLT-004)", "company_id": "BIZ-SU-HLT-004", "counterparty": "DeepHealth (RadNet)", "amount": null, "amount_text": null, "currency": null, "valuation_reported": null, "summary": "DeepHealth acquired the London breast-screening AI company; price not disclosed.", "sources_text": "https://htn.co.uk/2024/10/25/deephealth-acquires-ai-diagnostic-company-to-support-breast-cancer-care/ — \"has acquired London-based cancer diagnostic company Kheiron Medical Technologies Limited\" (accessed 2026-10-29)", "source_urls": [ "https://htn.co.uk/2024/10/25/deephealth-acquires-ai-diagnostic-company-to-support-breast-cancer-care/" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2024-10-25", "date_sort": "2024-10-25", "before_ledger_start": false, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-034", "date": "2024-10-15", "year": "2024", "kind": "funding_round", "company_text": "Shift Bioscience (BIZ-SU-HLT-025)", "company_id": "BIZ-SU-HLT-025", "counterparty": "BGF", "amount": 16000000, "amount_text": "16000000", "currency": "USD", "valuation_reported": null, "summary": "Seed round with F-Prime Capital, Kindred Capital and Jonathan Milner. [Labs Round 8] This is the £12.5m seed led by BGF (tech.eu, trade).", "sources_text": "https://www.uktech.news/ai/shift-bioscience-gen-ai-reverse-ageing-20241015 — \"closed a $16m (£12.2m) seed funding round\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/ai/shift-bioscience-gen-ai-reverse-ageing-20241015" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2024-10-15", "date_sort": "2024-10-15", "before_ledger_start": false, "amount_gbp": 12219337, "fx_rate": 1.3094, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.3094 per £ on 2024-10-15", "fx_date": "2024-10-15", "fx_note": "", "txt": "US$16m", "gbp_txt": "£12.2m", "show": true }, { "id": "DEAL-SU-HLT-035", "date": "2024-08-02", "year": "2024", "kind": "funding_round", "company_text": "Healx (BIZ-SU-HLT-037)", "company_id": "BIZ-SU-HLT-037", "counterparty": "R42 Group and Atomico", "amount": 47000000, "amount_text": "47000000", "currency": "USD", "valuation_reported": null, "summary": "Series C to take HLX-1502 into phase 2.", "sources_text": "https://www.uktech.news/medtech/healx-series-c-round-20240802 — \"led by R42 Group and Atomico\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/healx-series-c-round-20240802" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2024-08-02", "date_sort": "2024-08-02", "before_ledger_start": false, "amount_gbp": 36698680, "fx_rate": 1.2807, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.2807 per £ on 2024-08-02", "fx_date": "2024-08-02", "fx_note": "", "txt": "US$47m", "gbp_txt": "£36.7m", "show": true }, { "id": "DEAL-SU-HLT-036", "date": "2024-07-18", "year": "2024", "kind": "funding_round", "company_text": "Spotlight Pathology (BIZ-SU-HLT-012)", "company_id": "BIZ-SU-HLT-012", "counterparty": "LYVA Labs", "amount": 125000, "amount_text": "125000", "currency": "GBP", "valuation_reported": null, "summary": "Investment from LYVA Labs.", "sources_text": "https://www.uktech.news/medtech/spotlight-pathology-ai-blood-diagnosis-20240718 — \"has raised £125,000 in the latest investment from LYVA Labs.\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/spotlight-pathology-ai-blood-diagnosis-20240718" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2024-07-18", "date_sort": "2024-07-18", "before_ledger_start": false, "amount_gbp": 125000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£125,000", "gbp_txt": "£125,000", "show": true }, { "id": "DEAL-SU-HLT-037", "date": "2024-05-21", "year": "2024", "kind": "funding_round", "company_text": "LabGenius (BIZ-SU-HLT-038)", "company_id": "BIZ-SU-HLT-038", "counterparty": "M Ventures", "amount": 35000000, "amount_text": "35000000", "currency": "GBP", "valuation_reported": null, "summary": "Series B; total funding £58m.", "sources_text": "https://www.uktech.news/medtech/labgenius-drug-discovery-series-b-20240521 — \"The funding round was led by M Ventures.\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/labgenius-drug-discovery-series-b-20240521", "https://tech.eu/2024/05/22/labgenius-secures-ps35m-series-b-funding-for-therapeutic-antibody-discovery/" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2024-05-21", "date_sort": "2024-05-21", "before_ledger_start": false, "amount_gbp": 35000000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£35m", "gbp_txt": "£35m", "show": true }, { "id": "DEAL-SU-HLT-038", "date": "2024-04-16", "year": "2024", "kind": "funding_round", "company_text": "Qureight (BIZ-SU-HLT-009)", "company_id": "BIZ-SU-HLT-009", "counterparty": "Hargreave Hale AIM VCT", "amount": 8500000, "amount_text": "8500000", "currency": "USD", "valuation_reported": null, "summary": "Round for its medical data platform.", "sources_text": "https://www.uktech.news/medtech/qureight-funding-ai-medical-data-20240416 — \"The investment was led by Hargreave Hale AIM VCT\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/qureight-funding-ai-medical-data-20240416" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2024-04-16", "date_sort": "2024-04-16", "before_ledger_start": false, "amount_gbp": 6831699, "fx_rate": 1.2442, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.2442 per £ on 2024-04-16", "fx_date": "2024-04-16", "fx_note": "", "txt": "US$8.5m", "gbp_txt": "£6.8m", "show": true }, { "id": "DEAL-SU-HLT-039", "date": "2024-03-21", "year": "2024", "kind": "funding_round", "company_text": "Presymptom Health (BIZ-SU-HLT-026)", "company_id": "BIZ-SU-HLT-026", "counterparty": "UKI2S; Ploughshare; MedTechToMarket", "amount": 1500000, "amount_text": "1500000", "currency": "GBP", "valuation_reported": null, "summary": "Equity and grant funding.", "sources_text": "https://www.uktech.news/medtech/presymptom-health-ai-sepsis-20240321 — £1.5m equity and grant (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/presymptom-health-ai-sepsis-20240321" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2024-03-21", "date_sort": "2024-03-21", "before_ledger_start": false, "amount_gbp": 1500000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.5m", "gbp_txt": "£1.5m", "show": true }, { "id": "DEAL-SU-HLT-040", "date": "2024-03-15", "year": "2024", "kind": "funding_round", "company_text": "ThinkSono (BIZ-SU-HLT-047)", "company_id": "BIZ-SU-HLT-047", "counterparty": "Id4 Ventures", "amount": 2100000, "amount_text": "2100000", "currency": "GBP", "valuation_reported": null, "summary": "Round; total raised £5m.", "sources_text": "https://www.uktech.news/medtech/thinksono-ai-ultrasound-20240315 — £2.1m led by Id4 Ventures (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/thinksono-ai-ultrasound-20240315" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2024-03-15", "date_sort": "2024-03-15", "before_ledger_start": false, "amount_gbp": 2100000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£2.1m", "gbp_txt": "£2.1m", "show": true }, { "id": "DEAL-SU-HLT-041", "date": "2024-03-01", "year": "2024", "kind": "funding_round", "company_text": "Vitrue Health (BIZ-SU-HLT-050)", "company_id": "BIZ-SU-HLT-050", "counterparty": "MMC Ventures and Hambro Perks", "amount": 3200000, "amount_text": "3200000", "currency": "GBP", "valuation_reported": null, "summary": "Round.", "sources_text": "https://www.uktech.news/medtech/vitrue-health-funding-back-pain-20240301 — \"The funding round was led by MMC Ventures and Hambro Perks\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/vitrue-health-funding-back-pain-20240301" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2024-03-01", "date_sort": "2024-03-01", "before_ledger_start": false, "amount_gbp": 3200000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£3.2m", "gbp_txt": "£3.2m", "show": true }, { "id": "DEAL-SU-HLT-042", "date": "2024-02-26", "year": "2024", "kind": "funding_round", "company_text": "Adsilico (BIZ-SU-HLT-051)", "company_id": "BIZ-SU-HLT-051", "counterparty": "Northern Gritstone; Parkwalk Advisors", "amount": 3500000, "amount_text": "3500000", "currency": "GBP", "valuation_reported": null, "summary": "Round.", "sources_text": "https://www.uktech.news/medtech/ai-medical-testing-spinout-adsilico-20240226 — \"AI medical testing spinout Adsilico raises £3.5m\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/ai-medical-testing-spinout-adsilico-20240226" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2024-02-26", "date_sort": "2024-02-26", "before_ledger_start": false, "amount_gbp": 3500000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£3.5m", "gbp_txt": "£3.5m", "show": true }, { "id": "DEAL-SU-HLT-043", "date": "2024-02-13", "year": "2024", "kind": "funding_round", "company_text": "TORTUS (BIZ-SU-HLT-034)", "company_id": "BIZ-SU-HLT-034", "counterparty": "Khosla Ventures", "amount": 4200000, "amount_text": "4200000", "currency": "USD", "valuation_reported": null, "summary": "Round for its OSLER clinical AI assistant.", "sources_text": "https://www.uktech.news/ai/tortus-ai-assistant-funding-20240213 — \"The funding round was led by Khosla Ventures.\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/ai/tortus-ai-assistant-funding-20240213" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2024-02-13", "date_sort": "2024-02-13", "before_ledger_start": false, "amount_gbp": 3333069, "fx_rate": 1.2601, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.2601 per £ on 2024-02-13", "fx_date": "2024-02-13", "fx_note": "", "txt": "US$4.2m", "gbp_txt": "£3.3m", "show": true }, { "id": "DEAL-SU-HLT-044", "date": "2024-02-12", "year": "2024", "kind": "funding_round", "company_text": "AMPLY Discovery (BIZ-SU-HLT-048)", "company_id": "BIZ-SU-HLT-048", "counterparty": "Innovate UK (grant)", "amount": 1400000, "amount_text": "1400000", "currency": "GBP", "valuation_reported": null, "summary": "Grant funding for two projects.", "sources_text": "https://www.uktech.news/medtech/amply-ai-drug-grant-20240212 — \"has raised £1.4m in grant funding\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/amply-ai-drug-grant-20240212", "https://tech.eu/2024/02/12/belfast-based-amply-secures-ps14m-for-ai-powered-drug-discovery-platform/" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2024-02-12", "date_sort": "2024-02-12", "before_ledger_start": false, "amount_gbp": 1400000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.4m", "gbp_txt": "£1.4m", "show": true }, { "id": "DEAL-SU-HLT-045", "date": "2024-02-09", "year": "2024", "kind": "funding_round", "company_text": "Lilli (BIZ-SU-HLT-052)", "company_id": "BIZ-SU-HLT-052", "counterparty": "West Hill Capital", "amount": 8200000, "amount_text": "8200000", "currency": "GBP", "valuation_reported": null, "summary": "Round.", "sources_text": "https://www.uktech.news/medtech/lilli-raises-8-2m-20240209 — \"led by previous investor West Hill Capital\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/lilli-raises-8-2m-20240209" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2024-02-09", "date_sort": "2024-02-09", "before_ledger_start": false, "amount_gbp": 8200000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£8.2m", "gbp_txt": "£8.2m", "show": true }, { "id": "DEAL-SU-HLT-046", "date": "2024-02-06", "year": "2024", "kind": "funding_round", "company_text": "Sable Bio (BIZ-SU-HLT-049)", "company_id": "BIZ-SU-HLT-049", "counterparty": "Episode 1 Ventures", "amount": 1500000, "amount_text": "1500000", "currency": "GBP", "valuation_reported": null, "summary": "Pre-seed with Seedcamp.", "sources_text": "https://www.uktech.news/medtech/ai-drug-testing-startup-sable-bio-20240206 — \"The investment round was led by Episode 1 Ventures,\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/ai-drug-testing-startup-sable-bio-20240206" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2024-02-06", "date_sort": "2024-02-06", "before_ledger_start": false, "amount_gbp": 1500000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.5m", "gbp_txt": "£1.5m", "show": true }, { "id": "DEAL-SU-HLT-2046", "date": "2024-02-06", "year": "2024", "kind": "grant", "company_text": "RAIQC", "company_id": "BIZ-SU-HLT-2038", "counterparty": "UKRI Technology Missions Fund (Accelerating trustworthy AI, phase 2)", "amount": null, "amount_text": null, "currency": "GBP", "valuation_reported": null, "summary": "One of 21 projects sharing £19 million; individual amount not stated.", "sources_text": "https://www.ukri.org/news/19-million-to-accelerate-trustworthy-and-responsible-ai/ — \"Developing tools for pre-market evaluation and post-market surveillance of medical imaging AI\"", "source_urls": [ "https://www.ukri.org/news/19-million-to-accelerate-trustworthy-and-responsible-ai/" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2024-02-06", "date_sort": "2024-02-06", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-2048", "date": "2024-02-06", "year": "2024", "kind": "grant", "company_text": "Aival", "company_id": "BIZ-SAFE-017", "counterparty": "UKRI Technology Missions Fund (Accelerating trustworthy AI, phase 2)", "amount": null, "amount_text": null, "currency": "GBP", "valuation_reported": null, "summary": "One of 21 projects sharing £19 million; individual amount not stated.", "sources_text": "https://www.ukri.org/news/19-million-to-accelerate-trustworthy-and-responsible-ai/ — \"Accelerating trustworthy AI in radiology\"", "source_urls": [ "https://www.ukri.org/news/19-million-to-accelerate-trustworthy-and-responsible-ai/" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2024-02-06", "date_sort": "2024-02-06", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-2049", "date": "2024-02-06", "year": "2024", "kind": "grant", "company_text": "Newton's Tree", "company_id": "BIZ-SU-HLT-029", "counterparty": "UKRI Technology Missions Fund (Accelerating trustworthy AI, phase 2)", "amount": null, "amount_text": null, "currency": "GBP", "valuation_reported": null, "summary": "Federated AI monitoring service project; one of 21 sharing £19 million.", "sources_text": "https://www.ukri.org/news/19-million-to-accelerate-trustworthy-and-responsible-ai/ — \"Newton's Tree Limited … Federated AI monitoring service\"", "source_urls": [ "https://www.ukri.org/news/19-million-to-accelerate-trustworthy-and-responsible-ai/" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2024-02-06", "date_sort": "2024-02-06", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-LB-113", "date": "2024-01-16", "year": "2024", "kind": "funding_round", "company_text": "CellVoyant (new)", "company_id": "BIZ-SU-HLT-704", "counterparty": "Octopus Ventures", "amount": 7600000, "amount_text": "7600000", "currency": "GBP", "valuation_reported": null, "summary": "Bristol biotech using AI to predict stem-cell behaviour raised £7.6m seed.", "sources_text": "https://www.uktech.news/tech-hubs/south-west/bristol/bristol-biotech-cellvoyant-funding-20240116 (trade) — \"CellVoyant has secured £7.6m in funding\" … \"The seed funding round was led by Octopus Ventures.\"", "source_urls": [ "https://www.uktech.news/tech-hubs/south-west/bristol/bristol-biotech-cellvoyant-funding-20240116" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2024-01-16", "date_sort": "2024-01-16", "before_ledger_start": false, "amount_gbp": 7600000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£7.6m", "gbp_txt": "£7.6m", "show": true }, { "id": "DEAL-SU-HLT-047", "date": "2023-12-08", "year": "2023", "kind": "funding_round", "company_text": "Holly Health (BIZ-SU-HLT-054)", "company_id": "BIZ-SU-HLT-054", "counterparty": "Innovate UK; Plug and Play Ventures; Modality Partnership", "amount": 650000, "amount_text": "650000", "currency": "GBP", "valuation_reported": null, "summary": "Equity and grant round.", "sources_text": "https://www.uktech.news/medtech/holly-health-app-650k-20231208 — \"has secured £650,000 in a joint equity and grant funding round.\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/holly-health-app-650k-20231208" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2023-12-08", "date_sort": "2023-12-08", "before_ledger_start": false, "amount_gbp": 650000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£650,000", "gbp_txt": "£650,000", "show": true }, { "id": "DEAL-SU-HLT-048", "date": "2023-11-22", "year": "2023", "kind": "funding_round", "company_text": "Phare Health (BIZ-SU-HLT-053)", "company_id": "BIZ-SU-HLT-053", "counterparty": "General Catalyst", "amount": 2500000, "amount_text": "2500000", "currency": "GBP", "valuation_reported": null, "summary": "Round with KHP Ventures and Bertelsmann Investments.", "sources_text": "https://www.uktech.news/medtech/phare-health-funding-ai-20231122 — \"The funding round was led by General Catalyst\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/phare-health-funding-ai-20231122" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2023-11-22", "date_sort": "2023-11-22", "before_ledger_start": false, "amount_gbp": 2500000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£2.5m", "gbp_txt": "£2.5m", "show": true }, { "id": "DEAL-LAB-16014", "date": "2023-10-16", "year": "2023", "kind": "partnership", "company_text": "Antiverse", "company_id": "BIZ-SU-HLT-013", "counterparty": "GlobalBio, Inc.", "amount": null, "amount_text": "undisclosed", "currency": null, "valuation_reported": null, "summary": "Antiverse and GlobalBio extended their antibody cancer collaboration. For: antibody cancer therapeutics (extension).", "sources_text": "https://www.antiverse.io/news — \"Antiverse and GlobalBio, Inc. extend collaboration to advance antibody cancer therapeutics\"", "source_urls": [ "https://www.antiverse.io/news" ], "confidence": "single_source", "ledger": "page", "page": "labs", "render": true, "date_text": "2023-10-16", "date_sort": "2023-10-16", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true, "labs_r8": true }, { "id": "DEAL-SU-HLT-049", "date": "2023-09-21", "year": "2023", "kind": "funding_round", "company_text": "Decently (BIZ-SU-HLT-056)", "company_id": "BIZ-SU-HLT-056", "counterparty": "Praetura Ventures (GMC Life Sciences Fund)", "amount": 500000, "amount_text": "500000", "currency": "GBP", "valuation_reported": null, "summary": "Round with SFC Capital.", "sources_text": "https://www.uktech.news/medtech/brain-injury-ai-startup-20230921 — £500,000; \"SFC Capital also participated in the round.\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/brain-injury-ai-startup-20230921" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2023-09-21", "date_sort": "2023-09-21", "before_ledger_start": false, "amount_gbp": 500000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£500,000", "gbp_txt": "£500,000", "show": true }, { "id": "DEAL-SU-HLT-050", "date": "2023-09-20", "year": "2023", "kind": "funding_round", "company_text": "Navenio (BIZ-SU-HLT-041)", "company_id": "BIZ-SU-HLT-041", "counterparty": "Oxford Science Enterprises", "amount": 5000000, "amount_text": "5000000", "currency": "GBP", "valuation_reported": null, "summary": "Round to expand into the US.", "sources_text": "https://www.uktech.news/ai/indoor-mapping-navenio-5m-20230920 — \"Oxford Science Enterprises is leading a £5m investment into Navenio\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/ai/indoor-mapping-navenio-5m-20230920" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2023-09-20", "date_sort": "2023-09-20", "before_ledger_start": false, "amount_gbp": 5000000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£5m", "gbp_txt": "£5m", "show": true }, { "id": "DEAL-SU-HLT-051", "date": "2023-09-13", "year": "2023", "kind": "funding_round", "company_text": "Kuano (BIZ-SU-HLT-055)", "company_id": "BIZ-SU-HLT-055", "counterparty": "Mercia Ventures", "amount": 1800000, "amount_text": "1800000", "currency": "GBP", "valuation_reported": null, "summary": "Seed round.", "sources_text": "https://www.uktech.news/medtech/kuano-seed-20230913 — \"Mercia Ventures has led a £1.8m seed financing round.\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/kuano-seed-20230913", "https://tech.eu/2023/09/12/kuano-raises1-8m-for-drug-discovery/" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2023-09-13", "date_sort": "2023-09-13", "before_ledger_start": false, "amount_gbp": 1800000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.8m", "gbp_txt": "£1.8m", "show": true }, { "id": "DEAL-SU-HLT-052", "date": "2023-09-13", "year": "2023", "kind": "funding_round", "company_text": "Myma Medical (BIZ-SU-HLT-057)", "company_id": "BIZ-SU-HLT-057", "counterparty": "LYVA Labs", "amount": 145000, "amount_text": "145000", "currency": "GBP", "valuation_reported": null, "summary": "Investment.", "sources_text": "https://www.uktech.news/medtech/myma-medical-lyva-labs-funding-20230913 — \"AI fertility treatment startup Myma Medical secures £145k\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/myma-medical-lyva-labs-funding-20230913" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2023-09-13", "date_sort": "2023-09-13", "before_ledger_start": false, "amount_gbp": 145000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£145,000", "gbp_txt": "£145,000", "show": true }, { "id": "DEAL-SU-HLT-053", "date": "2023-08-31", "year": "2023", "kind": "acquisition", "company_text": "Babylon Health (BIZ-SU-HLT-001)", "company_id": "BIZ-SU-HLT-001", "counterparty": "eMed Healthcare UK Limited", "amount": null, "amount_text": null, "currency": null, "valuation_reported": null, "summary": "Administrators sold certain UK businesses and assets to eMed; sources disagree on whether GP at Hand was included.", "sources_text": "https://htn.co.uk/2023/08/31/digital-first-care-company-babylon-puts-two-divisions-into-administration/ — \"has secured the future of the Babylon UK operations\"; https://pharmaphorum.com/news/two-babylon-health-divisions-have-been-sold-emed — \"two of the company's divisions have been sold to US digital health business eMed\" (accessed 2026-10-29)", "source_urls": [ "https://htn.co.uk/2023/08/31/digital-first-care-company-babylon-puts-two-divisions-into-administration/", "https://pharmaphorum.com/news/two-babylon-health-divisions-have-been-sold-emed" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2023-08-31", "date_sort": "2023-08-31", "before_ledger_start": false, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-054", "date": "2023-08-31", "year": "2023", "kind": "funding_round", "company_text": "Mimetrik (BIZ-SU-HLT-058)", "company_id": "BIZ-SU-HLT-058", "counterparty": "Northern Gritstone", "amount": 2000000, "amount_text": "2000000", "currency": "GBP", "valuation_reported": null, "summary": "Round.", "sources_text": "https://www.uktech.news/medtech/mimetrik-raises-2m-20230831 — \"The investment was led by UK regional investor Northern Gritstone\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/mimetrik-raises-2m-20230831" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2023-08-31", "date_sort": "2023-08-31", "before_ledger_start": false, "amount_gbp": 2000000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£2m", "gbp_txt": "£2m", "show": true }, { "id": "DEAL-SU-HLT-055", "date": "2023-08-30", "year": "2023", "kind": "collapse", "company_text": "Babylon Health (BIZ-SU-HLT-001)", "company_id": "BIZ-SU-HLT-001", "counterparty": "Alvarez & Marsal (administrators)", "amount": null, "amount_text": null, "currency": null, "valuation_reported": null, "summary": "Babylon Group Holdings Limited and Babylon Partners Limited placed in administration.", "sources_text": "https://htn.co.uk/2023/08/31/digital-first-care-company-babylon-puts-two-divisions-into-administration/ — \"acting as administrators over Babylon Group Holdings Limited and subsidiary Babylon Partners Limited\"; https://find-and-update.company-information.service.gov.uk/company/08493276 — \"In Administration\" (accessed 2026-10-29)", "source_urls": [ "https://htn.co.uk/2023/08/31/digital-first-care-company-babylon-puts-two-divisions-into-administration/", "https://find-and-update.company-information.service.gov.uk/company/08493276" ], "confidence": "verified", "ledger": "page", "page": "startups", "render": true, "date_text": "2023-08-30", "date_sort": "2023-08-30", "before_ledger_start": false, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-056", "date": "2023-08-16", "year": "2023", "kind": "funding_round", "company_text": "Lindus Health (BIZ-SU-HLT-060)", "company_id": "BIZ-SU-HLT-060", "counterparty": "Creandum", "amount": 18000000, "amount_text": "18000000", "currency": "USD", "valuation_reported": null, "summary": "Series A with Peter Thiel, firstminute, Seedcamp, Hambro Perks, Amino Collective.", "sources_text": "https://www.uktech.news/medtech/lindus-health-series-a-20230816 — \"led by venture capital firm Creandum.\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/lindus-health-series-a-20230816" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2023-08-16", "date_sort": "2023-08-16", "before_ledger_start": false, "amount_gbp": 14114326, "fx_rate": 1.2753, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.2753 per £ on 2023-08-16", "fx_date": "2023-08-16", "fx_note": "", "txt": "US$18m", "gbp_txt": "£14.1m", "show": true }, { "id": "DEAL-SU-HLT-057", "date": "2023-07-27", "year": "2023", "kind": "funding_round", "company_text": "Thymia (BIZ-SU-HLT-061)", "company_id": "BIZ-SU-HLT-061", "counterparty": "Kodori Ventures", "amount": 2700000, "amount_text": "2700000", "currency": "USD", "valuation_reported": null, "summary": "Seed round.", "sources_text": "https://www.uktech.news/medtech/thymia-seed-round-20230727 — \"The investment round was led by Kodori Ventures.\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/thymia-seed-round-20230727" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2023-07-27", "date_sort": "2023-07-27", "before_ledger_start": false, "amount_gbp": 2101331, "fx_rate": 1.2849, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.2849 per £ on 2023-07-27", "fx_date": "2023-07-27", "fx_note": "", "txt": "US$2.7m", "gbp_txt": "£2.1m", "show": true }, { "id": "DEAL-SU-HLT-058", "date": "2023-07-14", "year": "2023", "kind": "funding_round", "company_text": "Causaly (BIZ-SU-HLT-062)", "company_id": "BIZ-SU-HLT-062", "counterparty": "ICONIQ Growth", "amount": 60000000, "amount_text": "60000000", "currency": "USD", "valuation_reported": null, "summary": "Series B.", "sources_text": "https://www.uktech.news/medtech/ai-biotech-research-platform-causaly-secures-45-8m-20230714 — \"led by ICONIQ Growth.\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/ai-biotech-research-platform-causaly-secures-45-8m-20230714" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2023-07-14", "date_sort": "2023-07-14", "before_ledger_start": false, "amount_gbp": 45745654, "fx_rate": 1.3116, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.3116 per £ on 2023-07-14", "fx_date": "2023-07-14", "fx_note": "", "txt": "US$60m", "gbp_txt": "£45.7m", "show": true }, { "id": "DEAL-SU-HLT-059", "date": "2023-06-26", "year": "2023", "kind": "delisting", "company_text": "Babylon Health (BIZ-SU-HLT-001)", "company_id": "BIZ-SU-HLT-001", "counterparty": "New York Stock Exchange", "amount": null, "amount_text": null, "currency": null, "valuation_reported": null, "summary": "Agreed to delist from the NYSE and become private again; expected to complete in July 2023.", "sources_text": "https://www.uktech.news/medtech/babylon-delist-from-new-york-20230626 — \"Babylon has agreed to delist itself from the New York Stock Exchange to become a private company again.\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/babylon-delist-from-new-york-20230626" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2023-06-26", "date_sort": "2023-06-26", "before_ledger_start": false, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-LB-077", "date": "2023-06-01", "year": "2023", "kind": "funding_round", "company_text": "Hypervision Surgical (new)", "company_id": "BIZ-SU-HLT-503", "counterparty": "HERAN Partners; Redalpine; LifeX Ventures; ZEISS Ventures (no lead named)", "amount": 6500000, "amount_text": "6500000", "currency": "GBP", "valuation_reported": null, "summary": "King's College London spinout combining AI and hyperspectral imaging for surgery raised £6.5m seed.", "sources_text": "https://www.uktech.news/medtech/hypervision-surgical-seed-20230601 (trade) — \"London-based AI medical imaging startup Hypervision Surgical has scooped £6.5m in an oversubscribed seed round.\"", "source_urls": [ "https://www.uktech.news/medtech/hypervision-surgical-seed-20230601" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2023-06-01", "date_sort": "2023-06-01", "before_ledger_start": false, "amount_gbp": 6500000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£6.5m", "gbp_txt": "£6.5m", "show": true }, { "id": "DEAL-LB-063", "date": "2023-03-09", "year": "2023", "kind": "funding_round", "company_text": "CanSense (new)", "company_id": "BIZ-SU-HLT-803", "counterparty": "Mercia; Development Bank of Wales; Nonacus (no lead named)", "amount": 1500000, "amount_text": "1500000", "currency": "GBP", "valuation_reported": null, "summary": "Swansea start-up with an AI and laser blood test for bowel cancer raised £1.5m.", "sources_text": "https://www.uktech.news/medtech/cansense-funding-20230309 (trade) — \"has raised £1.5m in funding\" … \"a blood test to detect bowel cancer that uses laser light and artificial intelligence (AI)\"", "source_urls": [ "https://www.uktech.news/medtech/cansense-funding-20230309" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2023-03-09", "date_sort": "2023-03-09", "before_ledger_start": false, "amount_gbp": 1500000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.5m", "gbp_txt": "£1.5m", "show": true }, { "id": "DEAL-SU-HLT-2044", "date": "2023-03-03", "year": "2023", "kind": "grant", "company_text": "Mendelian", "company_id": "BIZ-SU-HLT-068", "counterparty": "NHS AI Lab (AI in Health and Care Award, round 3)", "amount": null, "amount_text": null, "currency": "GBP", "valuation_reported": null, "summary": "NHS AI Award round 3 grant for MendelScan rare disease case-finding in primary care records.", "sources_text": "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners — \"MendelScan uses AI to diagnose rare diseases\" ; https://htn.co.uk/2023/03/03/9-projects-secure-funding-through-ai-in-health-and-care-award/ (trade) — \"matching patients to published diagnostic criteria for hundreds of rare diseases\"", "source_urls": [ "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners", "https://htn.co.uk/2023/03/03/9-projects-secure-funding-through-ai-in-health-and-care-award/" ], "confidence": "verified", "ledger": "page", "page": "startups", "render": true, "date_text": "2023-03-03", "date_sort": "2023-03-03", "before_ledger_start": false, "week_ending": false, "trade": true, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-2045", "date": "2023-03-03", "year": "2023", "kind": "grant", "company_text": "Oxford Cancer Biomarkers", "company_id": "BIZ-SU-HLT-069", "counterparty": "NHS AI Lab (AI in Health and Care Award, round 3)", "amount": null, "amount_text": null, "currency": "GBP", "valuation_reported": null, "summary": "NHS AI Award round 3 grant for OncoProg bowel cancer chemotherapy-benefit test.", "sources_text": "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners — \"OncoProg uses AI to help identify people who will benefit from chemotherapy\" ; https://htn.co.uk/2023/03/03/9-projects-secure-funding-through-ai-in-health-and-care-award/ (trade) — \"using AI to identify biomarkers – genes which may suggest a predisposition\"", "source_urls": [ "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners", "https://htn.co.uk/2023/03/03/9-projects-secure-funding-through-ai-in-health-and-care-award/" ], "confidence": "verified", "ledger": "page", "page": "startups", "render": true, "date_text": "2023-03-03", "date_sort": "2023-03-03", "before_ledger_start": false, "week_ending": false, "trade": true, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-LB-057", "date": "2023-02-07", "year": "2023", "kind": "funding_round", "company_text": "Syndi Health (new)", "company_id": "BIZ-SU-HLT-605", "counterparty": "Founders Factory; Plug and Play and others (no lead named)", "amount": 2000000, "amount_text": "2000000", "currency": "USD", "valuation_reported": null, "summary": "London AI wellbeing-recommendation platform raised $2m pre-seed.", "sources_text": "https://www.uktech.news/medtech/syndi-health-pre-seed-20230207 (trade) — \"London-based startup Syndi Health has secured $2m (£1.7m) in pre-seed funding\"", "source_urls": [ "https://www.uktech.news/medtech/syndi-health-pre-seed-20230207" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2023-02-07", "date_sort": "2023-02-07", "before_ledger_start": false, "amount_gbp": 1664586, "fx_rate": 1.2015, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.2015 per £ on 2023-02-07", "fx_date": "2023-02-07", "fx_note": "", "txt": "US$2m", "gbp_txt": "£1.7m", "show": true }, { "id": "DEAL-LB-056", "date": "2023-02-02", "year": "2023", "kind": "funding_round", "company_text": "Re:course AI (new)", "company_id": "BIZ-SU-HLT-802", "counterparty": "Par Equity", "amount": 4300000, "amount_text": "4300000", "currency": "USD", "valuation_reported": null, "summary": "Manchester healthcare-training platform using AI avatars raised $4.3m seed.", "sources_text": "https://www.uktech.news/medtech/recourse-ai-seed-20230202 (trade) — \"has raised $4.3m (£3.5m) in seed capital\" … \"Its seed round was led by Par Equity\"", "source_urls": [ "https://www.uktech.news/medtech/recourse-ai-seed-20230202" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2023-02-02", "date_sort": "2023-02-02", "before_ledger_start": false, "amount_gbp": 3496503, "fx_rate": 1.2298, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.2298 per £ on 2023-02-02", "fx_date": "2023-02-02", "fx_note": "", "txt": "US$4.3m", "gbp_txt": "£3.5m", "show": true }, { "id": "DEAL-LB-054", "date": "2023-01-24", "year": "2023", "kind": "funding_round", "company_text": "Waire Health (new)", "company_id": "BIZ-SU-HLT-604", "counterparty": "Eos Advisory; Scottish Enterprise (co-investor)", "amount": 2000000, "amount_text": "2000000", "currency": "GBP", "valuation_reported": null, "summary": "Edinburgh remote-monitoring medtech whose C-Detect device uses AI raised £2m.", "sources_text": "https://www.uktech.news/medtech/waire-health-funding-20230124 (trade) — \"The funding round was led by Eos Advisory alongside co-investor, Scottish Enterprise.\"", "source_urls": [ "https://www.uktech.news/medtech/waire-health-funding-20230124" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2023-01-24", "date_sort": "2023-01-24", "before_ledger_start": false, "amount_gbp": 2000000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£2m", "gbp_txt": "£2m", "show": true }, { "id": "DEAL-LB-053", "date": "2023-01-19", "year": "2023", "kind": "acquisition", "company_text": "Blackford Analysis (new)", "company_id": "BIZ-SU-HLT-703", "counterparty": "Bayer", "amount": null, "amount_text": null, "currency": null, "valuation_reported": null, "summary": "Bayer bought Edinburgh medical-imaging AI firm Blackford Analysis for an unspecified sum.", "sources_text": "https://www.uktech.news/growth-strategy/exit-strategy/bayer-buys-blackford-analysis-20230119 (trade) — \"German life science firm Bayer has acquired artificial intelligence company Blackford Analysis for an unspecified sum.\"", "source_urls": [ "https://www.uktech.news/growth-strategy/exit-strategy/bayer-buys-blackford-analysis-20230119" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2023-01-19", "date_sort": "2023-01-19", "before_ledger_start": false, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-LAB-16022", "date": "2023-01-09", "year": "2023", "kind": "grant", "company_text": "Kuano", "company_id": "BIZ-SU-HLT-055", "counterparty": "Innovate UK", "amount": null, "amount_text": "540,000 (project value)", "currency": "GBP", "valuation_reported": null, "summary": "Innovate UK funded a £540k Kuano cancer-drug project. For: design of a new generation of cancer drugs (NOTUM, colorectal cancer).", "sources_text": "https://www.kuano.ai/news/older/ — \"grant funding from Innovate UK for a £540,000 project\"", "source_urls": [ "https://www.kuano.ai/news/older/" ], "confidence": "single_source", "ledger": "page", "page": "labs", "render": true, "date_text": "2023-01-09", "date_sort": "2023-01-09", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_as_written": "540,000 (project value)", "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "540,000 (project value) GBP reported", "gbp_txt": "", "show": true, "labs_r8": true }, { "id": "DEAL-SU-HLT-069", "date": "2023-01-06", "year": "2023", "kind": "funding_round", "company_text": "Perspectum (BIZ-SU-HLT-064)", "company_id": "BIZ-SU-HLT-064", "counterparty": "Oppenheimer Holdings", "amount": 36000000, "amount_text": "36000000", "currency": "USD", "valuation_reported": null, "summary": "First round of Series C (£30.4m)", "sources_text": "https://www.uktech.news/medtech/perspectum-funding-20230106 — \"closed $36m (£30.4m) in its first round of Series C funding\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/perspectum-funding-20230106" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2023-01-06", "date_sort": "2023-01-06", "before_ledger_start": false, "amount_gbp": 29882958, "fx_rate": 1.2047, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.2047 per £ on 2023-01-06", "fx_date": "2023-01-06", "fx_note": "", "txt": "US$36m", "gbp_txt": "£29.9m", "show": true }, { "id": "DEAL-LB-044", "date": "2022-11-29", "year": "2022", "kind": "funding_round", "company_text": "Biorelate (new)", "company_id": "BIZ-SU-HLT-603", "counterparty": "YFM; Maven; Triple Point Ventures; Northern Powerhouse Investment Fund; Manchester Tech Trust angels (no lead named)", "amount": 6500000, "amount_text": "6500000", "currency": "GBP", "valuation_reported": null, "summary": "Manchester AI drug-discovery platform raised a £6.5m Series A.", "sources_text": "https://www.uktech.news/medtech/biorelate-series-a-20221129 (trade) — \"Manchester-based Biorelate has bagged £6.5m in Series A investment for its AI drug discovery platform for medical companies.\"", "source_urls": [ "https://www.uktech.news/medtech/biorelate-series-a-20221129" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2022-11-29", "date_sort": "2022-11-29", "before_ledger_start": false, "amount_gbp": 6500000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£6.5m", "gbp_txt": "£6.5m", "show": true }, { "id": "DEAL-LB-039", "date": "2022-10-20", "year": "2022", "kind": "funding_round", "company_text": "Nucleome Therapeutics (new)", "company_id": "BIZ-SU-HLT-702", "counterparty": "M Ventures", "amount": 37500000, "amount_text": "37500000", "currency": "GBP", "valuation_reported": null, "summary": "Oxford spinout using machine learning to predict disease-linked variants raised a £37.5m Series A.", "sources_text": "https://www.uktech.news/ai/nucleome-therapeutics-series-a-20221020 (trade) — \"has raised £37.5m in an oversubscribed Series A round.\" … \"Led by M Ventures.\"", "source_urls": [ "https://www.uktech.news/ai/nucleome-therapeutics-series-a-20221020" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2022-10-20", "date_sort": "2022-10-20", "before_ledger_start": false, "amount_gbp": 37500000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£37.5m", "gbp_txt": "£37.5m", "show": true }, { "id": "DEAL-SU-HLT-060", "date": "2022-10-17", "year": "2022", "kind": "rename", "company_text": "Sensyne Health (BIZ-SU-HLT-005)", "company_id": "BIZ-SU-HLT-005", "counterparty": "Arcturis Data Limited", "amount": null, "amount_text": null, "currency": null, "valuation_reported": null, "summary": "Renamed Arcturis Data Limited.", "sources_text": "https://find-and-update.company-information.service.gov.uk/company/11425451 — \"SENSYNE HEALTH LIMITED / 13 Jul 2022 – 17 Oct 2022\" \"ARCTURIS DATA LIMITED\" (accessed 2026-10-29)", "source_urls": [ "https://find-and-update.company-information.service.gov.uk/company/11425451" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2022-10-17", "date_sort": "2022-10-17", "before_ledger_start": false, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-061", "date": "2022-09-27", "year": "2022", "kind": "funding_round", "company_text": "Optellum (BIZ-SU-HLT-040)", "company_id": "BIZ-SU-HLT-040", "counterparty": "Mercia", "amount": 14000000, "amount_text": "14000000", "currency": "USD", "valuation_reported": null, "summary": "Series A.", "sources_text": "https://tech.eu/2022/09/27/oxford-based-medtech-optellum-gets-14-million-shot-to-accelerate-early-detection-of-lung-cancer/ — \"The Series A round was led by Mercia.\" (accessed 2026-10-29)", "source_urls": [ "https://tech.eu/2022/09/27/oxford-based-medtech-optellum-gets-14-million-shot-to-accelerate-early-detection-of-lung-cancer/" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2022-09-27", "date_sort": "2022-09-27", "before_ledger_start": false, "amount_gbp": 12994245, "fx_rate": 1.0774, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.0774 per £ on 2022-09-27", "fx_date": "2022-09-27", "fx_note": "", "txt": "US$14m", "gbp_txt": "£13m", "show": true }, { "id": "DEAL-LB-036", "date": "2022-09-21", "year": "2022", "kind": "funding_round", "company_text": "AMPLY Discovery (BIZ-SU-HLT-048)", "company_id": "BIZ-SU-HLT-048", "counterparty": "Co Fund NI; QUBIS Innovation Fund; Helix Way Partnership; HBAN angels (no lead named)", "amount": 900000, "amount_text": "900000", "currency": "GBP", "valuation_reported": null, "summary": "Belfast AI drug-discovery start-up raised £900,000 in equity and grant.", "sources_text": "https://www.uktech.news/medtech/amply-raises-900k-20220921 (trade) — \"Belfast-based startup AMPLY has raised £900,000 in a joint equity and grant funding round\"", "source_urls": [ "https://www.uktech.news/medtech/amply-raises-900k-20220921" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2022-09-21", "date_sort": "2022-09-21", "before_ledger_start": false, "amount_gbp": 900000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£900,000", "gbp_txt": "£900,000", "show": true }, { "id": "DEAL-SU-HLT-068", "date": "2022-08-04", "year": "2022", "kind": "funding_round", "company_text": "Cera (BIZ-SU-HLT-063)", "company_id": "BIZ-SU-HLT-063", "counterparty": "Schroders Capital; Jane Street Capital; KairosHQ; Vanderbilt University", "amount": 320000000, "amount_text": "320000000", "currency": "USD", "valuation_reported": null, "summary": "Equity and debt round (£263.6m)", "sources_text": "https://www.uktech.news/medtech/cera-health-tech-funding-20220804 — \"raised $320m (£263.6m) in an equity and debt funding round\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/cera-health-tech-funding-20220804" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2022-08-04", "date_sort": "2022-08-04", "before_ledger_start": false, "amount_gbp": 264222608, "fx_rate": 1.2111, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.2111 per £ on 2022-08-04", "fx_date": "2022-08-04", "fx_note": "", "txt": "US$320m", "gbp_txt": "£264.2m", "show": true }, { "id": "DEAL-LB-030", "date": "2022-07-28", "year": "2022", "kind": "funding_round", "company_text": "iLoF (new)", "company_id": "BIZ-SU-HLT-602", "counterparty": "Faber", "amount": 4100000, "amount_text": "4100000", "currency": "USD", "valuation_reported": null, "summary": "Oxford and Porto AI biomarker drug-discovery start-up raised funding led by a $4.1m equity investment.", "sources_text": "https://www.uktech.news/medtech/ilof-funding-20220728 (trade) — \"The bulk of the funding came in the form of a $4.1m equity investment led by Faber\"", "source_urls": [ "https://www.uktech.news/medtech/ilof-funding-20220728" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2022-07-28", "date_sort": "2022-07-28", "before_ledger_start": false, "amount_gbp": 3384514, "fx_rate": 1.2114, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.2114 per £ on 2022-07-28", "fx_date": "2022-07-28", "fx_note": "", "txt": "US$4.1m", "gbp_txt": "£3.4m", "show": true }, { "id": "DEAL-SU-HLT-062", "date": "2022-07-13", "year": "2022", "kind": "delisting", "company_text": "Sensyne Health (BIZ-SU-HLT-005)", "company_id": "BIZ-SU-HLT-005", "counterparty": null, "amount": null, "amount_text": null, "currency": null, "valuation_reported": null, "summary": "Re-registered from Sensyne Health plc to Sensyne Health Limited (private company).", "sources_text": "https://find-and-update.company-information.service.gov.uk/company/11425451 — \"SENSYNE HEALTH PLC / 13 Aug 2018 – 13 Jul 2022\" (accessed 2026-10-29)", "source_urls": [ "https://find-and-update.company-information.service.gov.uk/company/11425451" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2022-07-13", "date_sort": "2022-07-13", "before_ledger_start": false, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-LB-027", "date": "2022-07-06", "year": "2022", "kind": "funding_round", "company_text": "CardiaTec (new)", "company_id": "BIZ-SU-HLT-701", "counterparty": "Laidlaw Scholars Ventures; APEX Ventures", "amount": 1400000, "amount_text": "1400000", "currency": "GBP", "valuation_reported": null, "summary": "Cambridge start-up using AI for heart-disease target discovery raised £1.4m pre-seed.", "sources_text": "https://www.uktech.news/medtech/cardiatec-raises-1-4m-20220706 (trade) — \"Cambridge-based health tech startup CardiaTec has secured a £1.4m pre-seed investment\" … \"led by Laidlaw Scholars Ventures (LSV) and APEX Ventures.\"", "source_urls": [ "https://www.uktech.news/medtech/cardiatec-raises-1-4m-20220706" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2022-07-06", "date_sort": "2022-07-06", "before_ledger_start": false, "amount_gbp": 1400000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.4m", "gbp_txt": "£1.4m", "show": true }, { "id": "DEAL-LB-026", "date": "2022-07-01", "year": "2022", "kind": "funding_round", "company_text": "Holly Health (BIZ-SU-HLT-054)", "company_id": "BIZ-SU-HLT-054", "counterparty": "Kima Ventures and others (no lead named)", "amount": 1400000, "amount_text": "1400000", "currency": "GBP", "valuation_reported": null, "summary": "Digital health-coach app raised £1.4m.", "sources_text": "https://www.uktech.news/medtech/holly-health-age-uk-20220701 (trade) — \"Holly Health has raised £1.4m for its digital health coach app\" … \"The funding came from investors Kima Ventures\"", "source_urls": [ "https://www.uktech.news/medtech/holly-health-age-uk-20220701" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2022-07-01", "date_sort": "2022-07-01", "before_ledger_start": false, "amount_gbp": 1400000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.4m", "gbp_txt": "£1.4m", "show": true }, { "id": "DEAL-LB-021", "date": "2022-06-21", "year": "2022", "kind": "funding_round", "company_text": "Sonrai Analytics (BIZ-SU-HLT-071)", "company_id": "BIZ-SU-HLT-071", "counterparty": "Forward Partners", "amount": 2100000, "amount_text": "2100000", "currency": "GBP", "valuation_reported": null, "summary": "Belfast AI medical-software firm raised a £2.1m \"seed plus\" round.", "sources_text": "https://www.uktech.news/medtech/sonrai-analytics-2m-20220621 (trade) — \"has raised £2.1m in its “seed plus” round, led by venture capital firm Forward Partners\"", "source_urls": [ "https://www.uktech.news/medtech/sonrai-analytics-2m-20220621" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2022-06-21", "date_sort": "2022-06-21", "before_ledger_start": false, "amount_gbp": 2100000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£2.1m", "gbp_txt": "£2.1m", "show": true }, { "id": "DEAL-LB-015", "date": "2022-04-25", "year": "2022", "kind": "listing", "company_text": "BenevolentAI (BIZ-SU-HLT-002)", "company_id": "BIZ-SU-HLT-002", "counterparty": "Odyssey Acquisition S.A. (SPAC); Euronext Amsterdam", "amount": null, "amount_text": null, "currency": null, "valuation_reported": null, "summary": "AI drug-discovery company began trading on Euronext Amsterdam after a $1.7bn SPAC merger.", "sources_text": "https://www.uktech.news/medtech/benevolentai-dutch-market-ipo-20220425 (trade) — \"BenevolentAI has begun trading on Amsterdam’s Euronext market\" … \"BenevolentAI’s $1.7bn merger with special purpose acquisition company Odyssey Acquisition S.A in December.\"", "source_urls": [ "https://www.uktech.news/medtech/benevolentai-dutch-market-ipo-20220425" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2022-04-25", "date_sort": "2022-04-25", "before_ledger_start": false, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-PE-010", "date": "2022-04-25", "year": "2022", "kind": "listing", "company_text": "BenevolentAI (BIZ-SU-HLT-002)", "company_id": "BIZ-SU-HLT-002", "counterparty": "Euronext Amsterdam (via Odyssey Acquisition S.A., a SPAC), ticker BAI", "amount": null, "amount_text": null, "currency": null, "valuation_reported": "1500000000 EUR (up to, per tech.eu)", "summary": "Began trading on Euronext Amsterdam after combining with the Odyssey SPAC.", "sources_text": "https://www.euronext.com/en/about/media/euronext-press-releases/benevolentai-lists-euronext-amsterdam — \"3rd SPAC business combination on Euronext markets in 2022\"; https://tech.eu/2022/04/25/londons-benevolentai-lists-on-euronext-amsterdam-to-boost-drug-discovery-in-europe/ — \"has begun trading on Euronext Amsterdam\"", "source_urls": [ "https://www.euronext.com/en/about/media/euronext-press-releases/benevolentai-lists-euronext-amsterdam", "https://tech.eu/2022/04/25/londons-benevolentai-lists-on-euronext-amsterdam-to-boost-drug-discovery-in-europe/" ], "confidence": "verified", "ledger": "ledger2", "page": "startups", "render": true, "same_event_as": "DEAL-LB-015", "date_text": "2022-04-25", "date_sort": "2022-04-25", "before_ledger_start": false, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-2015", "date": "2022-02-06", "year": "2022", "kind": "grant", "company_text": "Pinpoint Data Science", "company_id": "BIZ-SU-HLT-2023", "counterparty": "SBRI Healthcare / NHS Cancer Programme", "amount": 752021, "amount_text": "752021", "currency": "GBP", "valuation_reported": null, "summary": "Late-stage SBRI cancer award to optimise urgent cancer referrals with an AI blood test.", "sources_text": "https://sbrihealthcare.co.uk/news/sbri-healthcare-awards-multi-million-pound-funding-for-late-stage-innovation-projects-that-advance-earlier-and-faster-diagnosis — \"Optimising NHS urgent cancer referral pathways with their AI-driven, affordable blood test\"", "source_urls": [ "https://sbrihealthcare.co.uk/news/sbri-healthcare-awards-multi-million-pound-funding-for-late-stage-innovation-projects-that-advance-earlier-and-faster-diagnosis" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2022-02-06", "date_sort": "2022-02-06", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": 752021, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£752,021", "gbp_txt": "£752,021", "show": true }, { "id": "DEAL-UG-014", "date": "2022", "year": "2022", "kind": "spin_out", "company_text": "AI Sight (new)", "company_id": "BIZ-SU-HLT-507", "counterparty": "University of Liverpool", "amount": null, "amount_text": null, "currency": null, "valuation_reported": null, "summary": "Spun out of Liverpool's Department of Eye and Vision Science.", "sources_text": "https://www.liverpool.ac.uk/collaborate/enterprise/spin-out-companies/ai-sight/ — \"spun out from the University in 2022.\"", "source_urls": [ "https://www.liverpool.ac.uk/collaborate/enterprise/spin-out-companies/ai-sight/" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2022 (day not stated)", "date_sort": "2022-00-00", "before_ledger_start": false, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-2039", "date": "2021-12-20", "year": "2021", "kind": "grant", "company_text": "Health Navigator", "company_id": "BIZ-SU-HLT-043", "counterparty": "SBRI Healthcare (urgent and emergency care)", "amount": 936697, "amount_text": "936697", "currency": "GBP", "valuation_reported": null, "summary": "SBRI award to deploy AI on NHS data to identify patients at risk.", "sources_text": "https://sbrihealthcare.co.uk/news/sbri-healthcare-awards-over-8-million-to-progress-pioneering-innovations-in-urgent-and-emergency-care-to-the-next-level/ — \"deploys artificial intelligence on NHS data to identify patients at risk\"", "source_urls": [ "https://sbrihealthcare.co.uk/news/sbri-healthcare-awards-over-8-million-to-progress-pioneering-innovations-in-urgent-and-emergency-care-to-the-next-level/" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2021-12-20", "date_sort": "2021-12-20", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": 936697, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£936,697", "gbp_txt": "£936,697", "show": true }, { "id": "DEAL-SU-HLT-2040", "date": "2021-12-20", "year": "2021", "kind": "grant", "company_text": "Re:course AI", "company_id": "BIZ-SU-HLT-802", "counterparty": "SBRI Healthcare (urgent and emergency care)", "amount": 860628, "amount_text": "860628", "currency": "GBP", "valuation_reported": null, "summary": "SBRI award (listed as Recourse AI) to cut time needed to train and assess clinicians.", "sources_text": "https://sbrihealthcare.co.uk/news/sbri-healthcare-awards-over-8-million-to-progress-pioneering-innovations-in-urgent-and-emergency-care-to-the-next-level/ — \"increasing NHS workforce capacity by cutting the time required to train, assess, and upskill clinicians\"", "source_urls": [ "https://sbrihealthcare.co.uk/news/sbri-healthcare-awards-over-8-million-to-progress-pioneering-innovations-in-urgent-and-emergency-care-to-the-next-level/" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2021-12-20", "date_sort": "2021-12-20", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": 860628, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£860,628", "gbp_txt": "£860,628", "show": true }, { "id": "DEAL-SU-HLT-2047", "date": "2021-12-20", "year": "2021", "kind": "grant", "company_text": "RAIQC", "company_id": "BIZ-SU-HLT-2038", "counterparty": "SBRI Healthcare (urgent and emergency care)", "amount": 697140, "amount_text": "697140", "currency": "GBP", "valuation_reported": null, "summary": "SBRI award for clinical image-interpretation simulation platform.", "sources_text": "https://sbrihealthcare.co.uk/news/sbri-healthcare-awards-over-8-million-to-progress-pioneering-innovations-in-urgent-and-emergency-care-to-the-next-level/ — \"RAIQC is a clinical simulation platform for medical image interpretation.\"", "source_urls": [ "https://sbrihealthcare.co.uk/news/sbri-healthcare-awards-over-8-million-to-progress-pioneering-innovations-in-urgent-and-emergency-care-to-the-next-level/" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2021-12-20", "date_sort": "2021-12-20", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": 697140, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£697,140", "gbp_txt": "£697,140", "show": true }, { "id": "DEAL-SU-HLT-063", "date": "2021-11-23", "year": "2021", "kind": "funding_round", "company_text": "ieso (BIZ-SU-HLT-039)", "company_id": "BIZ-SU-HLT-039", "counterparty": "Morningside", "amount": 53000000, "amount_text": "53000000", "currency": "USD", "valuation_reported": null, "summary": "Series B; total raised US$77.9m.", "sources_text": "https://tech.eu/2021/11/23/addressing-mental-health-with-digital-therapeutics-ieso-raises-53-million/ — \"Ieso's $53 million Series B round was led by Morningside\" (accessed 2026-10-29)", "source_urls": [ "https://tech.eu/2021/11/23/addressing-mental-health-with-digital-therapeutics-ieso-raises-53-million/" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2021-11-23", "date_sort": "2021-11-23", "before_ledger_start": false, "amount_gbp": 39640987, "fx_rate": 1.337, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.337 per £ on 2021-11-23", "fx_date": "2021-11-23", "fx_note": "", "txt": "US$53m", "gbp_txt": "£39.6m", "show": true }, { "id": "DEAL-LAB-4015", "date": "2021-07-08", "year": "2021", "kind": "funding_round", "company_text": "Kuano", "company_id": "BIZ-SU-HLT-055", "counterparty": "no lead named (ACF Investors; o2h Ventures)", "amount": 1000000, "amount_text": "1,000,000", "currency": "GBP", "valuation_reported": null, "summary": "Kuano raises a £1m seed round. For: Technology team, platform and own therapeutics. Other investors: Cambridge-based angel syndicate.", "sources_text": "https://www.uktech.news/ai/uk-biotech-startup-kuano-lands-1m-for-ai-driven-drug-discovery-20210707 (trade) — \"quantum physics, artificial intelligence (AI) and medicinal chemistry\"", "source_urls": [ "https://www.uktech.news/ai/uk-biotech-startup-kuano-lands-1m-for-ai-driven-drug-discovery-20210707" ], "confidence": "single_source", "ledger": "page", "page": "labs", "render": true, "date_text": "2021-07-08", "date_sort": "2021-07-08", "before_ledger_start": false, "week_ending": false, "trade": true, "round4": true, "amount_gbp": 1000000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1m", "gbp_txt": "£1m", "show": true, "labs_r7": true }, { "id": "DEAL-LAB-16023", "date": "2021-06-24", "year": "2021", "kind": "partnership", "company_text": "Kuano", "company_id": "BIZ-SU-HLT-055", "counterparty": "Alzheimer's Research UK UCL Drug Discovery Institute", "amount": null, "amount_text": "undisclosed", "currency": null, "valuation_reported": null, "summary": "Kuano agreed a research collaboration with the ARUK UCL Drug Discovery Institute.", "sources_text": "https://www.kuano.ai/news/older/ — \"research collaboration with the Alzheimer's Research UK University College London Drug Discovery Institute\"", "source_urls": [ "https://www.kuano.ai/news/older/" ], "confidence": "single_source", "ledger": "page", "page": "labs", "render": true, "date_text": "2021-06-24", "date_sort": "2021-06-24", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true, "labs_r8": true }, { "id": "DEAL-SU-HLT-2025", "date": "2021-06-16", "year": "2021", "kind": "grant", "company_text": "Behold.ai", "company_id": "BIZ-SU-HLT-067", "counterparty": "NHS AI Lab (AI in Health and Care Award, round 2)", "amount": null, "amount_text": null, "currency": "GBP", "valuation_reported": null, "summary": "NHS AI Award round 2 grant for chest X-ray analysis to fast-track suspected lung cancer.", "sources_text": "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care — \"fast-track the diagnosis of suspected lung cancer patients\"", "source_urls": [ "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2021-06-16", "date_sort": "2021-06-16", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-2026", "date": "2021-06-16", "year": "2021", "kind": "grant", "company_text": "Skin Analytics", "company_id": "BIZ-SU-HLT-066", "counterparty": "NHS AI Lab (AI in Health and Care Award, round 2, phase 4)", "amount": null, "amount_text": null, "currency": "GBP", "valuation_reported": null, "summary": "NHS AI Award phase 4 grant for DERM skin lesion analysis.", "sources_text": "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care — \"highlight the most likely cancers and aid in swift and appropriate treatment\" ; https://www.england.nhs.uk/aac/what-we-do/how-can-the-aac-help-me/ai-award/round-2-ai-in-health-and-care-awards/ — \"distinguishing between cancerous, pre-cancerous and benign lesions\"", "source_urls": [ "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care", "https://www.england.nhs.uk/aac/what-we-do/how-can-the-aac-help-me/ai-award/round-2-ai-in-health-and-care-awards/" ], "confidence": "verified", "ledger": "page", "page": "startups", "render": true, "date_text": "2021-06-16", "date_sort": "2021-06-16", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-2027", "date": "2021-06-16", "year": "2021", "kind": "grant", "company_text": "Caristo Diagnostics", "company_id": "BIZ-SU-HLT-070", "counterparty": "NHS AI Lab (AI in Health and Care Award, round 2, phase 3)", "amount": null, "amount_text": null, "currency": "GBP", "valuation_reported": null, "summary": "NHS AI Award phase 3 grant for CaRi-HEART heart inflammation detection on CT.", "sources_text": "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care — \"detect the invisible signatures of inflammation in the heart\" ; https://www.england.nhs.uk/aac/what-we-do/how-can-the-aac-help-me/ai-award/round-2-ai-in-health-and-care-awards/ — \"detect the invisible signatures of inflammation in the heart\"", "source_urls": [ "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care", "https://www.england.nhs.uk/aac/what-we-do/how-can-the-aac-help-me/ai-award/round-2-ai-in-health-and-care-awards/" ], "confidence": "verified", "ledger": "page", "page": "startups", "render": true, "date_text": "2021-06-16", "date_sort": "2021-06-16", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-2028", "date": "2021-06-16", "year": "2021", "kind": "grant", "company_text": "Navenio", "company_id": "BIZ-SU-HLT-041", "counterparty": "NHS AI Lab (AI in Health and Care Award, round 2, phase 3)", "amount": null, "amount_text": null, "currency": "GBP", "valuation_reported": null, "summary": "NHS AI Award phase 3 grant for AI hospital workforce deployment.", "sources_text": "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care — \"ensuring that both clinical and support staff are in the right place at the right time\" ; https://www.england.nhs.uk/aac/what-we-do/how-can-the-aac-help-me/ai-award/round-2-ai-in-health-and-care-awards/ — \"right place at the right time within a hospital\"", "source_urls": [ "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care", "https://www.england.nhs.uk/aac/what-we-do/how-can-the-aac-help-me/ai-award/round-2-ai-in-health-and-care-awards/" ], "confidence": "verified", "ledger": "page", "page": "startups", "render": true, "date_text": "2021-06-16", "date_sort": "2021-06-16", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-2029", "date": "2021-06-16", "year": "2021", "kind": "grant", "company_text": "Optellum", "company_id": "BIZ-SU-HLT-040", "counterparty": "NHS AI Lab (AI in Health and Care Award, round 2, phase 3)", "amount": null, "amount_text": null, "currency": "GBP", "valuation_reported": null, "summary": "NHS AI Award phase 3 grant for DOLCE lung nodule decision support.", "sources_text": "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care — \"examines lung nodules to determine which are precancerous\" ; https://www.england.nhs.uk/aac/what-we-do/how-can-the-aac-help-me/ai-award/round-2-ai-in-health-and-care-awards/ — \"AI decision support helps doctors make optimal decisions\"", "source_urls": [ "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care", "https://www.england.nhs.uk/aac/what-we-do/how-can-the-aac-help-me/ai-award/round-2-ai-in-health-and-care-awards/" ], "confidence": "verified", "ledger": "page", "page": "startups", "render": true, "date_text": "2021-06-16", "date_sort": "2021-06-16", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-2030", "date": "2021-06-16", "year": "2021", "kind": "grant", "company_text": "Storm ID", "company_id": "BIZ-SU-HLT-073", "counterparty": "NHS AI Lab (AI in Health and Care Award, round 2, phase 3)", "amount": null, "amount_text": null, "currency": "GBP", "valuation_reported": null, "summary": "NHS AI Award phase 3 grant for Lenus COPD Management Service.", "sources_text": "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care — \"to analyse output from patients’ daily monitoring and wearable devices\" ; https://www.england.nhs.uk/aac/what-we-do/how-can-the-aac-help-me/ai-award/round-2-ai-in-health-and-care-awards/ — \"predict deterioration, and enable targeted intervention\"", "source_urls": [ "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care", "https://www.england.nhs.uk/aac/what-we-do/how-can-the-aac-help-me/ai-award/round-2-ai-in-health-and-care-awards/" ], "confidence": "verified", "ledger": "page", "page": "startups", "render": true, "date_text": "2021-06-16", "date_sort": "2021-06-16", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-2031", "date": "2021-06-16", "year": "2021", "kind": "grant", "company_text": "MyWay Digital Health", "company_id": "BIZ-SU-HLT-072", "counterparty": "NHS AI Lab (AI in Health and Care Award, round 2, phase 2)", "amount": null, "amount_text": null, "currency": "GBP", "valuation_reported": null, "summary": "NHS AI Award phase 2 grant for MyDiabetes IQ.", "sources_text": "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care — \"for predicting diabetes complications and treatment choices\" ; https://www.england.nhs.uk/aac/what-we-do/how-can-the-aac-help-me/ai-award/round-2-ai-in-health-and-care-awards/ — \"predicting diabetes complications, sub-type diagnosis, and treatment choices\"", "source_urls": [ "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care", "https://www.england.nhs.uk/aac/what-we-do/how-can-the-aac-help-me/ai-award/round-2-ai-in-health-and-care-awards/" ], "confidence": "verified", "ledger": "page", "page": "startups", "render": true, "date_text": "2021-06-16", "date_sort": "2021-06-16", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-2032", "date": "2021-06-16", "year": "2021", "kind": "grant", "company_text": "Sonrai Analytics", "company_id": "BIZ-SU-HLT-071", "counterparty": "NHS AI Lab (AI in Health and Care Award, round 2, phase 2)", "amount": null, "amount_text": null, "currency": "GBP", "valuation_reported": null, "summary": "NHS AI Award phase 2 grant for ImageDx cancer biopsy analysis.", "sources_text": "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care — \"for faster and more accurate testing on cancer biopsy tissue\" ; https://www.england.nhs.uk/aac/what-we-do/how-can-the-aac-help-me/ai-award/round-2-ai-in-health-and-care-awards/ — \"faster and more accurate testing on cancer biopsy tissue\"", "source_urls": [ "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care", "https://www.england.nhs.uk/aac/what-we-do/how-can-the-aac-help-me/ai-award/round-2-ai-in-health-and-care-awards/" ], "confidence": "verified", "ledger": "page", "page": "startups", "render": true, "date_text": "2021-06-16", "date_sort": "2021-06-16", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-2033", "date": "2021-06-16", "year": "2021", "kind": "grant", "company_text": "Perspectum", "company_id": "BIZ-SU-HLT-064", "counterparty": "NHS AI Lab (AI in Health and Care Award, round 2, phase 2)", "amount": null, "amount_text": null, "currency": "GBP", "valuation_reported": null, "summary": "NHS AI Award phase 2 grant for First PLUS placenta measurement (University of Oxford-led, Perspectum partner).", "sources_text": "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care — \"to analyse the size of the placenta during the first trimester\" ; https://www.england.nhs.uk/aac/what-we-do/how-can-the-aac-help-me/ai-award/round-2-ai-in-health-and-care-awards/ — \"analyse the size of the placenta during the first trimester\"", "source_urls": [ "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care", "https://www.england.nhs.uk/aac/what-we-do/how-can-the-aac-help-me/ai-award/round-2-ai-in-health-and-care-awards/" ], "confidence": "verified", "ledger": "page", "page": "startups", "render": true, "date_text": "2021-06-16", "date_sort": "2021-06-16", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-2034", "date": "2021-06-16", "year": "2021", "kind": "grant", "company_text": "CyberLiver", "company_id": "BIZ-SU-HLT-074", "counterparty": "NHS AI Lab (AI in Health and Care Award, round 2, phase 1)", "amount": null, "amount_text": null, "currency": "GBP", "valuation_reported": null, "summary": "NHS AI Award phase 1 grant for CirrhoCare.", "sources_text": "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care — \"to better understand which will benefit from early ICU care\" ; https://www.england.nhs.uk/aac/what-we-do/how-can-the-aac-help-me/ai-award/round-2-ai-in-health-and-care-awards/ — \"predictive tool to guide whether patients will benefit from early hospital intervention\"", "source_urls": [ "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care", "https://www.england.nhs.uk/aac/what-we-do/how-can-the-aac-help-me/ai-award/round-2-ai-in-health-and-care-awards/" ], "confidence": "verified", "ledger": "page", "page": "startups", "render": true, "date_text": "2021-06-16", "date_sort": "2021-06-16", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-2035", "date": "2021-06-16", "year": "2021", "kind": "grant", "company_text": "Kheiron Medical Technologies", "company_id": "BIZ-SU-HLT-004", "counterparty": "NHS AI Lab (AI in Health and Care Award, round 2)", "amount": null, "amount_text": null, "currency": "GBP", "valuation_reported": null, "summary": "NHS AI Award grant for Mia breast screening reader.", "sources_text": "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care — \"aims to replace the need for 2 radiologists to review breast cancer scans\"", "source_urls": [ "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2021-06-16", "date_sort": "2021-06-16", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-LA-061", "date": "2021-05-11", "year": "2021", "kind": "funding_round", "company_text": "Huma (new)", "company_id": "BIZ-SU-HLT-801", "counterparty": "not stated in source", "amount": 130000000, "amount_text": "130000000", "currency": "USD", "valuation_reported": null, "summary": "Round for AI and biomarker patient monitoring and research platform.", "sources_text": "https://techcrunch.com/tag/huma/ — \"Huma, which uses AI and biomarkers to monitor patients and for medical research, raises $130M.\"", "source_urls": [ "https://techcrunch.com/tag/huma/" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2021-05-11", "date_sort": "2021-05-11", "before_ledger_start": false, "amount_gbp": 91911765, "fx_rate": 1.4144, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.4144 per £ on 2021-05-11", "fx_date": "2021-05-11", "fx_note": "", "txt": "US$130m", "gbp_txt": "£91.9m", "show": true }, { "id": "DEAL-LAB-4022", "date": "2021-03-18", "year": "2021", "kind": "funding_round", "company_text": "Antiverse", "company_id": "BIZ-SU-HLT-013", "counterparty": "angel syndicate led by Ed Parkinson", "amount": 1400000, "amount_text": "1,400,000", "currency": "GBP", "valuation_reported": null, "summary": "Antiverse raises a £1.4m seed round. For: Antibody drug discovery platform. Other investors: Development Bank of Wales; Angel Co-Investment Fund; Tensor Ventures; Wren Capital; Cambridge Angels; SyndicateRoom; UKI2S.", "sources_text": "https://www.uktech.news/featured/wales-antibody-drug-discovery-platform-antiverse-funding-20210318 (trade) — \"Founded in 2017 by Ben Holland, Murat Tunaboylu, and Rowina Westermeier\"", "source_urls": [ "https://www.uktech.news/featured/wales-antibody-drug-discovery-platform-antiverse-funding-20210318" ], "confidence": "single_source", "ledger": "page", "page": "labs", "render": true, "date_text": "2021-03-18", "date_sort": "2021-03-18", "before_ledger_start": false, "week_ending": false, "trade": true, "round4": true, "amount_gbp": 1400000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.4m", "gbp_txt": "£1.4m", "show": true, "labs_r7": true }, { "id": "DEAL-LAB-16021", "date": "2021-02-25", "year": "2021", "kind": "funding_round", "company_text": "Kuano", "company_id": "BIZ-SU-HLT-055", "counterparty": "o2h human health EIS Fund", "amount": null, "amount_text": "undisclosed", "currency": null, "valuation_reported": null, "summary": "Kuano raised a pre-seed round led by the o2h human health EIS Fund. Other investors: consortium (not named).", "sources_text": "https://www.kuano.ai/news/older/ — \"the o2h human health EIS Fund is leading a consortium of investors participating in a pre-seed round\"", "source_urls": [ "https://www.kuano.ai/news/older/" ], "confidence": "single_source", "ledger": "page", "page": "labs", "render": true, "date_text": "2021-02-25", "date_sort": "2021-02-25", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true, "labs_r8": true }, { "id": "DEAL-SU-HLT-070", "date": "2021-01-08", "year": "2021", "kind": "funding_round", "company_text": "Peptone (BIZ-SU-HLT-065)", "company_id": "BIZ-SU-HLT-065", "counterparty": "Hoxton Ventures", "amount": 2500000, "amount_text": "2500000", "currency": "USD", "valuation_reported": null, "summary": "Seed round (about £1.84m)", "sources_text": "https://www.uktech.news/news/uk-biotech-peptone-funding-for-faster-drug-discovery-20210108 — \"$2.5M (nearly £1.84M)\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/news/uk-biotech-peptone-funding-for-faster-drug-discovery-20210108" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2021-01-08", "date_sort": "2021-01-08", "before_ledger_start": false, "amount_gbp": 1839588, "fx_rate": 1.359, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.359 per £ on 2021-01-08", "fx_date": "2021-01-08", "fx_note": "", "txt": "US$2.5m", "gbp_txt": "£1.8m", "show": true }, { "id": "DEAL-SU-HLT-064", "date": "2021", "year": "2021", "kind": "listing", "company_text": "Babylon Health (BIZ-SU-HLT-001)", "company_id": "BIZ-SU-HLT-001", "counterparty": "New York Stock Exchange", "amount": null, "amount_text": null, "currency": null, "valuation_reported": "4200000000 USD", "summary": "Listed on the NYSE at a reported US$4.2bn valuation (year only).", "sources_text": "https://www.uktech.news/medtech/babylon-health-administration-20230831 — \"It was valued at $4.2bn when it listed on the New York Stock Exchange\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/medtech/babylon-health-administration-20230831" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2021", "date_sort": "2021-00-00", "before_ledger_start": false, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-065", "date": "2021", "year": "2021", "kind": "listing", "company_text": "Exscientia (BIZ-SU-HLT-003)", "company_id": "BIZ-SU-HLT-003", "counterparty": "Nasdaq", "amount": 510000000, "amount_text": "510000000", "currency": "USD", "valuation_reported": null, "summary": "IPO raising US$510m (as reported by Sifted, year only).", "sources_text": "https://sifted.eu/articles/ai-drug-discovery-startups — \"Its $510m IPO last year was one of the biggest ever in the biotech industry.\" (accessed 2026-10-29)", "source_urls": [ "https://sifted.eu/articles/ai-drug-discovery-startups" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2021", "date_sort": "2021-00-00", "before_ledger_start": false, "amount_gbp": 373653748, "fx_rate": 1.3649, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.3649 per £ on 2020-12-31", "fx_date": "2020-12-31", "fx_note": "year only given: rate for 1 January", "txt": "US$510m", "gbp_txt": "£373.7m", "show": true }, { "id": "DEAL-LAB-16002", "date": "2020-10-29", "year": "2020", "kind": "funding_round", "company_text": "LabGenius", "company_id": "BIZ-SU-HLT-038", "counterparty": "Atomico", "amount": 15000000, "amount_text": "15,000,000", "currency": "USD", "valuation_reported": null, "summary": "Atomico led a $15m extension that took LabGenius's Series A to $25m. For: Series A extension (round total $25m) for EVA platform. Other investors: Lux Capital; Obvious Ventures; Kindred Capital; Inovia Capital.", "sources_text": "https://tech.eu/2020/10/29/labgenius-series-a/ (trade) — \"LabGenius closes $15 million Series A extension led by Atomico, brings round to $25 million\"", "source_urls": [ "https://tech.eu/2020/10/29/labgenius-series-a/" ], "confidence": "single_source", "ledger": "page", "page": "labs", "render": true, "date_text": "2020-10-29", "date_sort": "2020-10-29", "before_ledger_start": false, "week_ending": false, "trade": true, "round4": true, "amount_gbp": 11623402, "fx_rate": 1.2905, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.2905 per £ on 2020-10-29", "fx_date": "2020-10-29", "fx_note": "", "txt": "US$15m reported", "gbp_txt": "£11.6m", "show": true, "labs_r8": true }, { "id": "DEAL-LA-051", "date": "2020-09-08", "year": "2020", "kind": "funding_round", "company_text": "Skin Analytics (BIZ-SU-HLT-066)", "company_id": "BIZ-SU-HLT-066", "counterparty": "not stated in source", "amount": 4000000, "amount_text": "4000000", "currency": "GBP", "valuation_reported": null, "summary": "Series A for AI skin-cancer screening.", "sources_text": "https://techcrunch.com/tag/skin-analytics/ — \"Skin Analytics raises £4M Series A to use AI for skin cancer screening\"", "source_urls": [ "https://techcrunch.com/tag/skin-analytics/" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2020-09-08", "date_sort": "2020-09-08", "before_ledger_start": false, "amount_gbp": 4000000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£4m", "gbp_txt": "£4m", "show": true }, { "id": "DEAL-SU-HLT-2001", "date": "2020-09-08", "year": "2020", "kind": "grant", "company_text": "Novoic", "company_id": "BIZ-SU-HLT-2001", "counterparty": "NHS AI Lab (AI in Health and Care Award, phase 1)", "amount": null, "amount_text": null, "currency": "GBP", "valuation_reported": null, "summary": "NHS AI Award phase 1 round 1 grant for Project Rhapsody speech-based disease detection.", "sources_text": "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners — \"This AI technology offers a novel way to analyse complex speech or language patterns\"", "source_urls": [ "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2020-09-08", "date_sort": "2020-09-08", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-2002", "date": "2020-09-08", "year": "2020", "kind": "grant", "company_text": "Mirada Medical", "company_id": "BIZ-SU-HLT-2002", "counterparty": "NHS AI Lab (AI in Health and Care Award, phase 1)", "amount": null, "amount_text": null, "currency": "GBP", "valuation_reported": null, "summary": "NHS AI Award phase 1 grant for AI review of radiotherapy treatment plans.", "sources_text": "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners — \"using AI for review of RT treatment plans for cancer patients\"", "source_urls": [ "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2020-09-08", "date_sort": "2020-09-08", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-2003", "date": "2020-09-08", "year": "2020", "kind": "grant", "company_text": "Neuronostics", "company_id": "BIZ-SU-HLT-2003", "counterparty": "NHS AI Lab (AI in Health and Care Award, phases 1 and 2)", "amount": null, "amount_text": null, "currency": "GBP", "valuation_reported": null, "summary": "Two NHS AI Award round 1 grants: smartphone EEG app (phase 1) and BioEP (phase 2).", "sources_text": "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners — \"BioEP is a computer biomarker of epilepsy\"", "source_urls": [ "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2020-09-08", "date_sort": "2020-09-08", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-2004", "date": "2020-09-08", "year": "2020", "kind": "grant", "company_text": "Senti Tech", "company_id": "BIZ-SU-HLT-2004", "counterparty": "NHS AI Lab (AI in Health and Care Award, phase 1)", "amount": null, "amount_text": null, "currency": "GBP", "valuation_reported": null, "summary": "NHS AI Award phase 1 grant for remote chest examination device.", "sources_text": "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners — \"a device which enables remote chest examination for respiratory patients\"", "source_urls": [ "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2020-09-08", "date_sort": "2020-09-08", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-2005", "date": "2020-09-08", "year": "2020", "kind": "grant", "company_text": "Nine Health Global", "company_id": "BIZ-SU-HLT-2005", "counterparty": "NHS AI Lab (AI in Health and Care Award, phase 1)", "amount": null, "amount_text": null, "currency": "GBP", "valuation_reported": null, "summary": "NHS AI Award phase 1 grant for Woubot wound-care software.", "sources_text": "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners — \"This project will create a suite of automated software tools for community and wound clinics\"", "source_urls": [ "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2020-09-08", "date_sort": "2020-09-08", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-2006", "date": "2020-09-08", "year": "2020", "kind": "grant", "company_text": "Advanced Expert Systems", "company_id": "BIZ-SU-HLT-2006", "counterparty": "NHS AI Lab (AI in Health and Care Award, phase 1)", "amount": null, "amount_text": null, "currency": "GBP", "valuation_reported": null, "summary": "NHS AI Award phase 1 grant for colonoscopy prioritisation model.", "sources_text": "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners — \"This project will develop a computer model to identify potential cases of bowel cancer or polyps\"", "source_urls": [ "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2020-09-08", "date_sort": "2020-09-08", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-2007", "date": "2020-09-08", "year": "2020", "kind": "grant", "company_text": "Macusoft", "company_id": "BIZ-SU-HLT-2007", "counterparty": "NHS AI Lab (AI in Health and Care Award, phase 1)", "amount": null, "amount_text": null, "currency": "GBP", "valuation_reported": null, "summary": "NHS AI Award phase 1 grant for eye-stability software.", "sources_text": "https://digitalhealth.london/accelerator-smes-among-winners-of-ai-in-health-and-care-award — \"Among the 42 successful winners were 7 DigitalHealth.London Accelerator SMEs\"", "source_urls": [ "https://digitalhealth.london/accelerator-smes-among-winners-of-ai-in-health-and-care-award" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2020-09-08", "date_sort": "2020-09-08", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-2008", "date": "2020-09-08", "year": "2020", "kind": "grant", "company_text": "Odin Vision", "company_id": "BIZ-SU-HLT-2008", "counterparty": "NHS AI Lab (AI in Health and Care Award, phase 2)", "amount": null, "amount_text": null, "currency": "GBP", "valuation_reported": null, "summary": "NHS AI Award phase 2 grant for FORE-AI polyp detection project.", "sources_text": "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners — \"award winning AI technology assists doctors to detect and characterise polyps\"", "source_urls": [ "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2020-09-08", "date_sort": "2020-09-08", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-2009", "date": "2020-09-08", "year": "2020", "kind": "grant", "company_text": "Xim (Lifelight)", "company_id": "BIZ-SU-HLT-2009", "counterparty": "NHS AI Lab (AI in Health and Care Award, phase 2)", "amount": null, "amount_text": null, "currency": "GBP", "valuation_reported": null, "summary": "NHS AI Award phase 2 grant for contactless blood pressure measurement.", "sources_text": "https://digitalhealth.london/accelerator-smes-among-winners-of-ai-in-health-and-care-award — \"Among the 42 successful winners were 7 DigitalHealth.London Accelerator SMEs\"", "source_urls": [ "https://digitalhealth.london/accelerator-smes-among-winners-of-ai-in-health-and-care-award" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2020-09-08", "date_sort": "2020-09-08", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-2010", "date": "2020-09-08", "year": "2020", "kind": "grant", "company_text": "Dem Dx", "company_id": "BIZ-SU-HLT-2010", "counterparty": "NHS AI Lab (AI in Health and Care Award, phase 2)", "amount": null, "amount_text": null, "currency": "GBP", "valuation_reported": null, "summary": "NHS AI Award phase 2 grant for ophthalmology triage support.", "sources_text": "https://digitalhealth.london/accelerator-smes-among-winners-of-ai-in-health-and-care-award — \"Among the 42 successful winners were 7 DigitalHealth.London Accelerator SMEs\"", "source_urls": [ "https://digitalhealth.london/accelerator-smes-among-winners-of-ai-in-health-and-care-award" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2020-09-08", "date_sort": "2020-09-08", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-2011", "date": "2020-09-08", "year": "2020", "kind": "grant", "company_text": "BreatheOx (Albus Health)", "company_id": "BIZ-SU-HLT-2011", "counterparty": "NHS AI Lab (AI in Health and Care Award, phase 2)", "amount": null, "amount_text": null, "currency": "GBP", "valuation_reported": null, "summary": "NHS AI Award phase 2 grant for home asthma-monitoring device.", "sources_text": "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners — \"a small table-top device that can automatically monitor a range of symptoms and metrics\"", "source_urls": [ "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2020-09-08", "date_sort": "2020-09-08", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-2012", "date": "2020-09-08", "year": "2020", "kind": "grant", "company_text": "Ufonia", "company_id": "BIZ-SU-HLT-2012", "counterparty": "NHS AI Lab (AI in Health and Care Award, phase 2)", "amount": null, "amount_text": null, "currency": "GBP", "valuation_reported": null, "summary": "NHS AI Award phase 2 grant for telephone AI assistant in cataract follow-up.", "sources_text": "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners — \"Ufonia's natural-language AI assistant delivered via a normal telephone call\"", "source_urls": [ "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2020-09-08", "date_sort": "2020-09-08", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-2013", "date": "2020-09-08", "year": "2020", "kind": "grant", "company_text": "Oxford Heartbeat", "company_id": "BIZ-SU-HLT-2013", "counterparty": "NHS AI Lab (AI in Health and Care Award, phase 3)", "amount": null, "amount_text": null, "currency": "GBP", "valuation_reported": null, "summary": "NHS AI Award phase 3 grant to test PreSize Neurovascular.", "sources_text": "https://digitalhealth.london/accelerator-smes-among-winners-of-ai-in-health-and-care-award — \"Among the 42 successful winners were 7 DigitalHealth.London Accelerator SMEs\"", "source_urls": [ "https://digitalhealth.london/accelerator-smes-among-winners-of-ai-in-health-and-care-award" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2020-09-08", "date_sort": "2020-09-08", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-2036", "date": "2020-09-08", "year": "2020", "kind": "grant", "company_text": "Kheiron Medical Technologies", "company_id": "BIZ-SU-HLT-004", "counterparty": "NHS AI Lab (AI in Health and Care Award, round 1, phase 4)", "amount": null, "amount_text": null, "currency": "GBP", "valuation_reported": null, "summary": "NHS AI Award round 1 phase 4 grant for Mia Mammography Intelligent Assessment.", "sources_text": "https://www.england.nhs.uk/aac/what-we-do/how-can-the-aac-help-me/ai-award/round-1/ — \"Deep learning software\" ; https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners — \"Deep learning software that has been developed to solve critical challenges\"", "source_urls": [ "https://www.england.nhs.uk/aac/what-we-do/how-can-the-aac-help-me/ai-award/round-1/", "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners" ], "confidence": "verified", "ledger": "page", "page": "startups", "render": true, "date_text": "2020-09-08", "date_sort": "2020-09-08", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-2037", "date": "2020-09-08", "year": "2020", "kind": "grant", "company_text": "Brainomix", "company_id": "BIZ-SU-HLT-006", "counterparty": "NHS AI Lab (AI in Health and Care Award, round 1, phase 4)", "amount": null, "amount_text": null, "currency": "GBP", "valuation_reported": null, "summary": "NHS AI Award round 1 phase 4 grant for e-Stroke Suite.", "sources_text": "https://www.england.nhs.uk/aac/what-we-do/how-can-the-aac-help-me/ai-award/round-1/ — \"uses AI methods to interpret acute stroke brain scans\" ; https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners — \"A set of tools that uses AI methods to interpret acute stroke brain scans\"", "source_urls": [ "https://www.england.nhs.uk/aac/what-we-do/how-can-the-aac-help-me/ai-award/round-1/", "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners" ], "confidence": "verified", "ledger": "page", "page": "startups", "render": true, "date_text": "2020-09-08", "date_sort": "2020-09-08", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-2038", "date": "2020-09-08", "year": "2020", "kind": "grant", "company_text": "Ultromics", "company_id": "BIZ-SU-HLT-007", "counterparty": "NHS AI Lab (AI in Health and Care Award, round 1, phase 4)", "amount": null, "amount_text": null, "currency": "GBP", "valuation_reported": null, "summary": "NHS AI Award round 1 phase 4 grant for EchoGo Pro stress echo analysis.", "sources_text": "https://www.england.nhs.uk/aac/what-we-do/how-can-the-aac-help-me/ai-award/round-1/ — \"A fully automated and scalable application for quantification and interpretation of stress echocardiograms\" ; https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners — \"A fully automated and scalable application for quantification and interpretation of stress echocardiograms\"", "source_urls": [ "https://www.england.nhs.uk/aac/what-we-do/how-can-the-aac-help-me/ai-award/round-1/", "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners" ], "confidence": "verified", "ledger": "page", "page": "startups", "render": true, "date_text": "2020-09-08", "date_sort": "2020-09-08", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-066", "date": "2020-05-21", "year": "2020", "kind": "funding_round", "company_text": "Navenio (BIZ-SU-HLT-041)", "company_id": "BIZ-SU-HLT-041", "counterparty": "QBN Capital", "amount": 9000000, "amount_text": "9000000", "currency": "GBP", "valuation_reported": null, "summary": "Series A.", "sources_text": "https://www.uktech.news/news/navenio-raises-9m-for-hospital-workforce-ai-platform-wednesday-20200518 — \"The series A funding round was led by QBN Capital\" (accessed 2026-10-29)", "source_urls": [ "https://www.uktech.news/news/navenio-raises-9m-for-hospital-workforce-ai-platform-wednesday-20200518" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2020-05-21", "date_sort": "2020-05-21", "before_ledger_start": false, "amount_gbp": 9000000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£9m", "gbp_txt": "£9m", "show": true }, { "id": "DEAL-LA-046", "date": "2020-04-15", "year": "2020", "kind": "rename", "company_text": "Huma (new), formerly Medopad", "company_id": "BIZ-SU-HLT-801", "counterparty": null, "amount": null, "amount_text": null, "currency": null, "valuation_reported": null, "summary": "Medopad renamed itself Huma.", "sources_text": "https://techcrunch.com/tag/huma/ — \"Medopad rebrands as Huma, acquires BioBeats and TLT to expand its biomarker platform.\"", "source_urls": [ "https://techcrunch.com/tag/huma/" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2020-04-15", "date_sort": "2020-04-15", "before_ledger_start": false, "matched_by": "alias", "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-LA-047", "date": "2020-04-15", "year": "2020", "kind": "acquisition", "company_text": "BioBeats (new)", "company_id": "BIZ-SU-HLT-601", "counterparty": "Huma (formerly Medopad)", "amount": null, "amount_text": null, "currency": null, "valuation_reported": null, "summary": "London-based Huma bought mental-health AI start-up BioBeats (location of BioBeats not stated in source) and TLT.", "sources_text": "https://techcrunch.com/2020/04/15/medopad-rebrands-as-huma-acquires-biobeats-and-tlt-to-expand-its-biomarker-platform/ — \"acquisition of two AI startups to expand the scope of its business: the mental health-focused BioBeats\"", "source_urls": [ "https://techcrunch.com/2020/04/15/medopad-rebrands-as-huma-acquires-biobeats-and-tlt-to-expand-its-biomarker-platform/" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2020-04-15", "date_sort": "2020-04-15", "before_ledger_start": false, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true }, { "id": "DEAL-SU-HLT-2014", "date": "2020-02-06", "year": "2020", "kind": "grant", "company_text": "Oxford Heartbeat", "company_id": "BIZ-SU-HLT-2013", "counterparty": "SBRI Healthcare", "amount": 100000, "amount_text": "100000", "currency": "GBP", "valuation_reported": null, "summary": "SBRI Healthcare cardiovascular award for stent graft planning and rehearsal software.", "sources_text": "https://sbrihealthcare.co.uk/news/sbri-healthcare-awards-1-million-to-pioneering-innovations-in-cardiovascular-disease-and-integrated-care-social-care/ — \"helps clinicians to accurately plan and rehearse minimally invasive stent graft replacements\"", "source_urls": [ "https://sbrihealthcare.co.uk/news/sbri-healthcare-awards-1-million-to-pioneering-innovations-in-cardiovascular-disease-and-integrated-care-social-care/" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2020-02-06", "date_sort": "2020-02-06", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": 100000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£100,000", "gbp_txt": "£100,000", "show": true }, { "id": "DEAL-SU-HLT-2018", "date": "2020-02-06", "year": "2020", "kind": "grant", "company_text": "Nelus AI", "company_id": "BIZ-SU-HLT-2026", "counterparty": "SBRI Healthcare", "amount": 99516, "amount_text": "99516", "currency": "GBP", "valuation_reported": null, "summary": "SBRI phase 1 award for AI-enabled hearing test bot.", "sources_text": "https://sbrihealthcare.co.uk/news/sbri-healthcare-awards-1-million-to-pioneering-innovations-in-cardiovascular-disease-and-integrated-care-social-care/ — \"Integration of an outreach hearing test with an AI-enabled BOT\"", "source_urls": [ "https://sbrihealthcare.co.uk/news/sbri-healthcare-awards-1-million-to-pioneering-innovations-in-cardiovascular-disease-and-integrated-care-social-care/" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2020-02-06", "date_sort": "2020-02-06", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": 99516, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£99,516", "gbp_txt": "£99,516", "show": true }, { "id": "DEAL-SU-HLT-2019", "date": "2020-02-06", "year": "2020", "kind": "grant", "company_text": "Upstream Health (Bridgit)", "company_id": "BIZ-SU-HLT-2027", "counterparty": "SBRI Healthcare", "amount": 90023, "amount_text": "90023", "currency": "GBP", "valuation_reported": null, "summary": "SBRI phase 1 award for Bridgit home support system.", "sources_text": "https://sbrihealthcare.co.uk/news/sbri-healthcare-awards-1-million-to-pioneering-innovations-in-cardiovascular-disease-and-integrated-care-social-care/ — \"Bridgit™ is a support system helping elderly people keep well and independent\"", "source_urls": [ "https://sbrihealthcare.co.uk/news/sbri-healthcare-awards-1-million-to-pioneering-innovations-in-cardiovascular-disease-and-integrated-care-social-care/" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": "2020-02-06", "date_sort": "2020-02-06", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": 90023, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£90,023", "gbp_txt": "£90,023", "show": true }, { "id": "DEAL-LA-035", "date": "2019-10-22", "year": "2019", "kind": "funding_round", "company_text": "LabGenius (BIZ-SU-HLT-038)", "company_id": "BIZ-SU-HLT-038", "counterparty": "not stated in source", "amount": 10000000, "amount_text": "10000000", "currency": "USD", "valuation_reported": null, "summary": "Round for AI protein drug discovery.", "sources_text": "https://techcrunch.com/tag/labgenius/ — \"LabGenius raises $10M to use AI for protein drug discovery\"", "source_urls": [ "https://techcrunch.com/tag/labgenius/" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2019-10-22", "date_sort": "2019-10-22", "before_ledger_start": false, "amount_gbp": 7747134, "fx_rate": 1.2908, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.2908 per £ on 2019-10-22", "fx_date": "2019-10-22", "fx_note": "", "txt": "US$10m", "gbp_txt": "£7.7m", "show": true }, { "id": "DEAL-LA-033", "date": "2019-10-16", "year": "2019", "kind": "funding_round", "company_text": "Healx (BIZ-SU-HLT-037)", "company_id": "BIZ-SU-HLT-037", "counterparty": "Atomico", "amount": 56000000, "amount_text": "56000000", "currency": "USD", "valuation_reported": null, "summary": "Series B for AI search for rare-disease treatments, Cambridge.", "sources_text": "https://techcrunch.com/2019/10/16/healx/ — \"has raised $56 million in Series B funding. Leading the round is London-base VC firm Atomico\"", "source_urls": [ "https://techcrunch.com/2019/10/16/healx/" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2019-10-16", "date_sort": "2019-10-16", "before_ledger_start": false, "amount_gbp": 43736332, "fx_rate": 1.2804, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.2804 per £ on 2019-10-16", "fx_date": "2019-10-16", "fx_note": "", "txt": "US$56m", "gbp_txt": "£43.7m", "show": true }, { "id": "DEAL-LA-031", "date": "2019-08-02", "year": "2019", "kind": "funding_round", "company_text": "Babylon Health (BIZ-SU-HLT-001)", "company_id": "BIZ-SU-HLT-001", "counterparty": "PIF; ERGO Fund (Munich Re); Kinnevik; Vostok New Ventures; others (no lead named)", "amount": 550000000, "amount_text": "550000000", "currency": "USD", "valuation_reported": "more than 2000000000 USD", "summary": "Series C for AI-based health services.", "sources_text": "https://techcrunch.com/2019/08/02/babylon-health-confirms-550m-raise-to-expand-its-ai-based-health-services-to-the-us-and-asia/ — \"It has closed a $550 million round of funding, valuing Babylon Health at more than $2 billion\"", "source_urls": [ "https://techcrunch.com/2019/08/02/babylon-health-confirms-550m-raise-to-expand-its-ai-based-health-services-to-the-us-and-asia/" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2019-08-02", "date_sort": "2019-08-02", "before_ledger_start": false, "amount_gbp": 453533438, "fx_rate": 1.2127, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.2127 per £ on 2019-08-02", "fx_date": "2019-08-02", "fx_note": "", "txt": "US$550m", "gbp_txt": "£453.5m", "show": true }, { "id": "DEAL-LA-030", "date": "2019-07-15", "year": "2019", "kind": "funding_round", "company_text": "Optellum (BIZ-SU-HLT-040)", "company_id": "BIZ-SU-HLT-040", "counterparty": "Luminous Ventures; IQ Capital; St John's College Oxford", "amount": 3250000, "amount_text": "3250000", "currency": "GBP", "valuation_reported": null, "summary": "Seed follow-on round (£1m from Luminous) for AI lung-cancer diagnosis, Oxford.", "sources_text": "https://tech.eu/2019/07/15/optellum-scores-1-million-funding-for-ai-driven-lung-cancer-diagnosis/ (trade) — \"has just raised £1 million from Luminous Ventures, as part of a seed follow-on round of £3.25 million\"", "source_urls": [ "https://tech.eu/2019/07/15/optellum-scores-1-million-funding-for-ai-driven-lung-cancer-diagnosis/" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2019-07-15", "date_sort": "2019-07-15", "before_ledger_start": false, "amount_gbp": 3250000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£3.2m", "gbp_txt": "£3.2m", "show": true }, { "id": "DEAL-LA-011", "date": "2018-05-02", "year": "2018", "kind": "funding_round", "company_text": "Cera (BIZ-SU-HLT-063)", "company_id": "BIZ-SU-HLT-063", "counterparty": "not stated in source", "amount": 17000000, "amount_text": "17000000", "currency": "USD", "valuation_reported": null, "summary": "Series A for homecare services company building AI decision support.", "sources_text": "https://techcrunch.com/tag/cera/ — \"Homecare services startup Cera announces $17M Series A\"", "source_urls": [ "https://techcrunch.com/tag/cera/" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2018-05-02", "date_sort": "2018-05-02", "before_ledger_start": false, "amount_gbp": 12500919, "fx_rate": 1.3599, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.3599 per £ on 2018-05-02", "fx_date": "2018-05-02", "fx_note": "", "txt": "US$17m", "gbp_txt": "£12.5m", "show": true }, { "id": "DEAL-LA-010", "date": "2018-04-18", "year": "2018", "kind": "funding_round", "company_text": "BenevolentAI (BIZ-SU-HLT-002)", "company_id": "BIZ-SU-HLT-002", "counterparty": "Woodford Investment Management; family offices and strategic backers", "amount": 115000000, "amount_text": "115000000", "currency": "USD", "valuation_reported": "2100000000 USD (post-money)", "summary": "Round for AI drug discovery.", "sources_text": "https://techcrunch.com/2018/04/18/benevolentai-which-uses-ai-to-develop-drugs-and-energy-solutions-nabs-115m-at-2b-valuation/ — \"BenevolentAI, which uses AI to develop drugs and energy solutions, nabs $115M at $2B valuation\"", "source_urls": [ "https://techcrunch.com/2018/04/18/benevolentai-which-uses-ai-to-develop-drugs-and-energy-solutions-nabs-115m-at-2b-valuation/" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2018-04-18", "date_sort": "2018-04-18", "before_ledger_start": false, "amount_gbp": 80786793, "fx_rate": 1.4235, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.4235 per £ on 2018-04-18", "fx_date": "2018-04-18", "fx_note": "", "txt": "US$115m", "gbp_txt": "£80.8m", "show": true }, { "id": "DEAL-LAB-16001", "date": "2017-11-24", "year": "2017", "kind": "funding_round", "company_text": "LabGenius", "company_id": "BIZ-SU-HLT-038", "counterparty": "Kindred Capital; Acequia Capital (co-leads)", "amount": 3660000, "amount_text": "3,660,000", "currency": "USD", "valuation_reported": null, "summary": "LabGenius raised a $3.66m seed round. For: London R&D centre and EVA evolution engine. Other investors: Berggruen Holdings; Backed VC; Beast Ventures; System.One; Charlie Songhurst; Tom McInerney.", "sources_text": "https://tech.eu/2017/11/24/labgenius-funding/ (trade) — \"EVA is a Silicon Scientist hooked up to a bank of liquid handling robots.\"", "source_urls": [ "https://tech.eu/2017/11/24/labgenius-funding/" ], "confidence": "single_source", "ledger": "page", "page": "labs", "render": true, "date_text": "2017-11-24", "date_sort": "2017-11-24", "before_ledger_start": false, "week_ending": false, "trade": true, "round4": true, "amount_gbp": 2741368, "fx_rate": 1.3351, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.3351 per £ on 2017-11-24", "fx_date": "2017-11-24", "fx_note": "", "txt": "US$3.7m reported", "gbp_txt": "£2.7m", "show": true, "labs_r8": true }, { "id": "DEAL-LA-002", "date": "2017-04-25", "year": "2017", "kind": "funding_round", "company_text": "Babylon Health (BIZ-SU-HLT-001)", "company_id": "BIZ-SU-HLT-001", "counterparty": "not stated in source", "amount": 60000000, "amount_text": "60000000", "currency": "USD", "valuation_reported": null, "summary": "Round to build out AI doctor app.", "sources_text": "https://techcrunch.com/tag/babylon-health/ — \"Babylon Health raises further $60M to continue building out AI doctor app\"", "source_urls": [ "https://techcrunch.com/tag/babylon-health/" ], "confidence": "single_source", "ledger": "ledger2", "page": "startups", "render": true, "date_text": "2017-04-25", "date_sort": "2017-04-25", "before_ledger_start": false, "amount_gbp": 46769039, "fx_rate": 1.2829, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.2829 per £ on 2017-04-25", "fx_date": "2017-04-25", "fx_note": "", "txt": "US$60m", "gbp_txt": "£46.8m", "show": true }, { "id": "DEAL-SU-HLT-067", "date": null, "year": null, "kind": "funding_round", "company_text": "GeneralPractice.AI (BIZ-SU-HLT-059)", "company_id": "BIZ-SU-HLT-059", "counterparty": "Deepbridge Capital", "amount": 250000, "amount_text": "250000", "currency": "GBP", "valuation_reported": null, "summary": "Investment (date not given).", "sources_text": "https://futurescot.com/glasgow-ai-assistant-for-gps-eyes-new-markets-after-securing-250000-investment/ — \"securing £250,000 investment\" (accessed 2026-10-29)", "source_urls": [ "https://futurescot.com/glasgow-ai-assistant-for-gps-eyes-new-markets-after-securing-250000-investment/" ], "confidence": "single_source", "ledger": "page", "page": "startups", "render": true, "date_text": null, "date_sort": null, "before_ledger_start": false, "amount_gbp": 250000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£250,000", "gbp_txt": "£250,000", "show": true }, { "id": "DEAL-LAB-12018", "date": null, "year": null, "kind": "partnership", "company_text": "Antiverse", "company_id": "BIZ-SU-HLT-013", "counterparty": "Nxera Pharma", "amount": null, "amount_text": "undisclosed", "currency": null, "valuation_reported": null, "summary": "Nxera Pharma and Antiverse collaborate on GPCR antibodies For: GPCR-targeted antibody therapeutics designed with generative AI.", "sources_text": "https://www.antiverse.io/news — \"Nxera Pharma and Antiverse Enter Collaboration To Design Novel GPCR-Targeted Antibody Therapeutics Using Generative AI\"", "source_urls": [ "https://www.antiverse.io/news" ], "confidence": "single_source", "ledger": "page", "page": "labs", "render": true, "date_text": "by 2024-12-28 (announcement date not shown)", "date_sort": "", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true, "labs_r8": true }, { "id": "DEAL-LAB-16015", "date": null, "year": null, "kind": "partnership", "company_text": "Antiverse", "company_id": "BIZ-SU-HLT-013", "counterparty": "Nxera Pharma", "amount": null, "amount_text": "undisclosed", "currency": null, "valuation_reported": null, "summary": "Nxera Pharma and Antiverse began a GPCR antibody collaboration. For: GPCR-targeted antibody design using generative AI.", "sources_text": "https://www.antiverse.io/news — \"Nxera Pharma and Antiverse Enter Collaboration To Design Novel GPCR-Targeted Antibody Therapeutics Using Generative AI\"", "source_urls": [ "https://www.antiverse.io/news" ], "confidence": "single_source", "ledger": "page", "page": "labs", "render": true, "date_text": "— (on or before 2024-12-28; newsletter date)", "date_sort": "", "before_ledger_start": false, "week_ending": false, "trade": false, "round4": true, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "", "show": true, "labs_r8": true } ] }